Elizabeth G. and Gary J. Nabel Family Professor Professor of Medicine
Pandit A, Leblebjian H, Hammond SP, Laubach JP, Richardson PG, Baden LR, Marty FM, Issa NC
Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2018 07; 53(7):942-945.
Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation.
Prevention and therapy of fungal infections in bone marrow transplantation. Leukemia. 2003 Jun; 17(6):1038-41.
Prevention and therapy of fungal infections in bone marrow transplantation.
Fischer MA, Lilly CM, Churchill WW, Baden LR, Avorn J
An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre. Drug Saf. 2004; 27(15):1253-61.
An algorithmic computerised order entry approach to assist in the prescribing of new therapeutic agents: case study of activated protein C at an academic medical centre.
Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR
Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother. 2006 Oct; 50(10):3450-3.
Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.
Goepfert PA, Tomaras GD, Horton H, Montefiori D, Ferrari G, Deers M, Voss G, Koutsoukos M, Pedneault L, Vandepapeliere P, McElrath MJ, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Baden LR, Harro C, Evans T
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers. Vaccine. 2007 Jan 05; 25(3):510-8.
Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers.
Farahani RM, Marsee DK, Baden LR, Woo SB, Treister NS
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
Trigeminal trophic syndrome with features of oral CMV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Sep; 106(3):e15-8.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
Trigeminal trophic syndrome with features of oral CMV disease.
Freifeld AG, Baden LR, Brown AE, Elting LS, Gelfand M, Greene JN, Ito JI, King E, Marcucci G, Montoya JG, Morris A, Noskin G, Rolston K, Schott AF, Segal B
Journal of the National Comprehensive Cancer Network : JNCCN
Fever and neutropenia clinical practice guidelines. J Natl Compr Canc Netw. 2004 Sep; 2(5):390-432.
Fever and neutropenia clinical practice guidelines.
Cheng C, Gall JG, Nason M, King CR, Koup RA, Roederer M, McElrath MJ, Morgan CA, Churchyard G, Baden LR, Duerr AC, Keefer MC, Graham BS, Nabel GJ
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. J Virol. 2010 Jan; 84(1):630-8.
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.
Wilck MB, Seaman MS, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Kleinjan JA, Noble LC, Stevenson KE, Kim HT, Dolin R
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration. J Infect Dis. 2010 May 01; 201(9):1361-70.
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.
Kubiak DW, Bryar JM, McDonnell AM, Delgado-Flores JO, Mui E, Baden LR, Marty FM
Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis. Clin Ther. 2010 Apr; 32(4):637-48.
Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Baden LR, Walsh SR, Seaman MS, Cohen YZ, Johnson JA, Licona JH, Filter RD, Kleinjan JA, Gothing JA, Jennings J, Peter L, Nkolola J, Abbink P, Borducchi EN, Kirilova M, Stephenson KE, Pegu P, Eller MA, Trinh HV, Rao M, Ake JA, Sarnecki M, Nijs S, Callewaert K, Schuitemaker H, Hendriks J, Pau MG, Tomaka F, Korber BT, Alter G, Dolin R, Earl PL, Moss B, Michael NL, Robb ML, Barouch DH
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector. J Infect Dis. 2018 07 13; 218(4):633-644.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
Grandpre LE, Duke-Cohan JS, Ewald BA, Devoy C, Barouch DH, Letvin NL, Reinherz EL, Baden LR, Dolin R, Seaman MS
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys. Vaccine. 2009 Mar 04; 27(10):1549-56.
Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
When to start antiretroviral therapy--ready when you are? N Engl J Med. 2009 Apr 30; 360(18):1897-9.
When to start antiretroviral therapy--ready when you are?
Kubiak DW, Koo S, Hammond SP, Armand P, Baden LR, Antin JH, Marty FM
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. Biol Blood Marrow Transplant. 2012 Sep; 18(9):1462-5.
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants.
Kelly RS, Lasky-Su J, Yeung SJ, Stone RM, Caterino JM, Hagan SC, Lyman GH, Baden LR, Glotzbecker BE, Coyne CJ, Baugh CW, Pallin DJ
Integrative omics to detect bacteremia in patients with febrile neutropenia. PLoS One. 2018; 13(5):e0197049.
Integrative omics to detect bacteremia in patients with febrile neutropenia.
Russell ND, Graham BS, Keefer MC, McElrath MJ, Self SG, Weinhold KJ, Montefiori DC, Ferrari G, Horton H, Tomaras GD, Gurunathan S, Baglyos L, Frey SE, Mulligan MJ, Harro CD, Buchbinder SP, Baden LR, Blattner WA, Koblin BA, Corey L
Journal of acquired immune deficiency syndromes (1999)
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial. J Acquir Immune Defic Syndr. 2007 Feb 01; 44(2):203-12.
Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial.
Seeley WW, Marty FM, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, Baden LR, Bromfield EB
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007 Jul 10; 69(2):156-65.
Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6.
Clinical decisions. Management of skin and soft-tissue infection--polling results. N Engl J Med. 2008 Oct 09; 359(15):e20.
Clinical decisions. Management of skin and soft-tissue infection--polling results.
Marty FM, Barouch DH, Coakley EP, Baden LR
Disseminated trichosporonosis caused by Trichosporon loubieri. J Clin Microbiol. 2003 Nov; 41(11):5317-20.
Disseminated trichosporonosis caused by Trichosporon loubieri.
Drazen JM, Curfman GD, Baden LR, Morrissey S
Compounding errors. N Engl J Med. 2012 Dec 20; 367(25):2436-7.
Cheng MP, Pandit A, Antin JH, Walsh SR, Huynh D, Ghobrial IM, Baden LR, Marty FM, Issa NC
Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation. Blood Adv. 2018 06 12; 2(11):1272-1276.
Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantation.
Freifeld AG, Sepkowitz KA, Martino P, Steven N, Billingham L, Cullen M, Baden LR
Antibacterial prophylaxis in patients with cancer and neutropenia. N Engl J Med. 2006 Jan 05; 354(1):90-4; author reply 90-4.
Antibacterial prophylaxis in patients with cancer and neutropenia.
Lowry CM, Marty FM, Vargas SO, Lee JT, Fiumara K, Deykin A, Baden LR
Transplant infectious disease : an official journal of the Transplantation Society
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study. Transpl Infect Dis. 2007 Jun; 9(2):121-5.
Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
Sullivan KM, Dykewicz CA, Longworth DL, Boeckh M, Baden LR, Rubin RH, Sepkowitz KA
Hematology. American Society of Hematology. Education Program
Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond. Hematology Am Soc Hematol Educ Program. 2001; 392-421.
Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.
Preexposure prophylaxis for HIV--where do we go from here? N Engl J Med. 2012 Aug 02; 367(5):459-61.
Preexposure prophylaxis for HIV--where do we go from here?
Exploiting Viruses to Treat Diseases. N Engl J Med. 2018 07 12; 379(2):194-196.
Churchyard GJ, Morgan C, Adams E, Hural J, Graham BS, Moodie Z, Grove D, Gray G, Bekker LG, McElrath MJ, Tomaras GD, Goepfert P, Kalams S, Baden LR, Lally M, Dolin R, Blattner W, Kalichman A, Figueroa JP, Pape J, Schechter M, Defawe O, De Rosa SC, Montefiori DC, Nabel GJ, Corey L, Keefer MC
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS One. 2011; 6(8):e21225.
A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204).
Transplant international : official journal of the European Society for Organ Transplantation
Darwinian competition and the pathogenesis of opportunistic infection in the transplant recipient. Transpl Int. 2005 Nov; 18(11):1223-5.
Darwinian competition and the pathogenesis of opportunistic infection in the transplant recipient.
Lerman MA, Laudenbach J, Marty FM, Baden LR, Treister NS
Management of oral infections in cancer patients. Dent Clin North Am. 2008 Jan; 52(1):129-53, ix.
Management of oral infections in cancer patients.
Vaccination after stem cell transplant: a review of recent developments and implications for current practice. Curr Opin Infect Dis. 2008 Aug; 21(4):399-408.
Vaccination after stem cell transplant: a review of recent developments and implications for current practice.
Baden LR, Digumarthy SR, Guimaraes AS, Branda JA
Case records of the Massachusetts General Hospital. Case 35-2009. A 60-year-old male renal-transplant recipient with renal insufficiency, diabetic ketoacidosis, and mental-status changes. N Engl J Med. 2009 Nov 12; 361(20):1980-9.
Case records of the Massachusetts General Hospital. Case 35-2009. A 60-year-old male renal-transplant recipient with renal insufficiency, diabetic ketoacidosis, and mental-status changes.
Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, Michael NL, Peter L, Nkolola JP, Borducchi EN, Chandrashekar A, Jetton D, Stephenson KE, Li W, Korber B, Tomaras GD, Montefiori DC, Gray G, Frahm N, McElrath MJ, Baden L, Johnson J, Hutter J, Swann E, Karita E, Kibuuka H, Mpendo J, Garrett N, Mngadi K, Chinyenze K, Priddy F, Lazarus E, Laher F, Nitayapan S, Pitisuttithum P, Bart S, Campbell T, Feldman R, Lucksinger G, Borremans C, Callewaert K, Roten R, Sadoff J, Scheppler L, Weijtens M, Feddes-de Boer K, van Manen D, Vreugdenhil J, Zahn R, Lavreys L, Nijs S, Tolboom J, Hendriks J, Euler Z, Pau MG, Schuitemaker H
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19). Lancet. 2018 07 21; 392(10143):232-243.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Hammond SP, Martin ST, Roberts K, Gabardi S, Fuhlbrigge AL, Camp PC, Goldberg HJ, Marty FM, Baden LR
Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis. Transpl Infect Dis. 2013 Apr; 15(2):163-70.
Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.
Knoll BM, Hammond SP, Koo S, Issa NC, Tullius SG, Baden LR, Pomahac B, Marty FM
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Infections following facial composite tissue allotransplantation--single center experience and review of the literature. Am J Transplant. 2013 Mar; 13(3):770-9.
Infections following facial composite tissue allotransplantation--single center experience and review of the literature.
Oxman DA, Issa NC, Marty FM, Patel A, Panizales CZ, Johnson NN, Licona JH, McKenna SS, Frendl G, Mentzer SJ, Jaklitsch MT, Bueno R, Colson Y, Swanson SJ, Sugarbaker DJ, Baden LR
Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. JAMA Surg. 2013 May; 148(5):440-6.
Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial.
Antibiotic prophylaxis for patients with acute leukemia. Leuk Lymphoma. 2008 Feb; 49(2):183-93.
Antibiotic prophylaxis for patients with acute leukemia.
Sparrow D, Weiss ST, Thomas HE, Rosner B, Baden L
The relationship of the U wave to the 10-year incidence of myocardial infarction. Am J Epidemiol. 1983 Jun; 117(6):729-34.
The relationship of the U wave to the 10-year incidence of myocardial infarction.
The effect of retirement on physical health. Am J Public Health. 1983 Jul; 73(7):779-83.
The effect of retirement on physical health.
Kalams SA, Parker S, Jin X, Elizaga M, Metch B, Wang M, Hural J, Lubeck M, Eldridge J, Cardinali M, Blattner WA, Sobieszczyk M, Suriyanon V, Kalichman A, Weiner DB, Baden LR
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults. PLoS One. 2012; 7(1):e29231.
Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults.
Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J, Armand P, Alyea EP, Baden LR, Antin JH, Soiffer RJ, Marty FM
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant. 2012 Nov; 18(11):1638-48.
Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
Marty FM, Petschnigg EM, Hammond SP, Ready JE, Ho VT, Soiffer RJ, Magee C, Milner DA, Antin JH, Baden LR
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Invasive fungal disease after remote inoculation in transplant recipients. Clin Infect Dis. 2011 Jan 01; 52(1):e7-10.
Invasive fungal disease after remote inoculation in transplant recipients.
Loechelt BJ, Boulware D, Green M, Baden LR, Gottlieb P, Krause-Steinrauf H, Weinberg A
Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetil. Clin Infect Dis. 2013 Jan; 56(2):248-54.
Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetil.
Barouch DH, Liu J, Peter L, Abbink P, Iampietro MJ, Cheung A, Alter G, Chung A, Dugast AS, Frahm N, McElrath MJ, Wenschuh H, Reimer U, Seaman MS, Pau MG, Weijtens M, Goudsmit J, Walsh SR, Dolin R, Baden LR
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001). J Infect Dis. 2013 Jan 15; 207(2):248-56.
Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).
Baden LR, Walsh SR, Seaman MS, Tucker RP, Krause KH, Patel A, Johnson JA, Kleinjan J, Yanosick KE, Perry J, Zablowsky E, Abbink P, Peter L, Iampietro MJ, Cheung A, Pau MG, Weijtens M, Goudsmit J, Swann E, Wolff M, Loblein H, Dolin R, Barouch DH
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001). J Infect Dis. 2013 Jan 15; 207(2):240-7.
First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
Walsh SR, Seaman MS, Grandpre LE, Charbonneau C, Yanosick KE, Metch B, Keefer MC, Dolin R, Baden LR
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 2012 Dec 17; 31(1):114-9.
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.
(1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann Intern Med. 2007 Jul 03; 147(1):70-2.
(1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.
Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci G, Montoya JG, Engemann AM, Rolston K, The AS
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw. 2008 Feb; 6(2):122-74.
Prevention and treatment of cancer-related infections.
Clinical problem-solving. Chest pain with a surprising course. N Engl J Med. 1999 Oct 07; 341(15):1134-8.
Clinical problem-solving. Chest pain with a surprising course.
Gansner JM, Rahmani M, Jonsson AH, Fortin BM, Brimah I, Ellis M, Smeland-Wagman R, Li ZJ, Schenkel JM, Brenner MB, Yefidoff-Freedman R, Sloan SR, Berliner N, Issa NC, Baden LR, Longo DL, Wesemann DR, Neuberg D, Rao DA, Kaufman RM
Plateletpheresis-associated lymphopenia in frequent platelet donors. Blood. 2019 02 07; 133(6):605-614.
Plateletpheresis-associated lymphopenia in frequent platelet donors.
Cheng MP, Kusztos AE, Gustine JN, Dryden-Peterson SL, Dubeau TE, Woolley AE, Hammond SP, Baden LR, Treon SP, Castillo JJ, Issa NC
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib. Br J Haematol. 2019 05; 185(4):788-790.
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinib.
Baden LR, Thiemke W, Skolnik A, Chambers R, Strymish J, Gold HS, Moellering RC, Eliopoulos GM
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". Clin Infect Dis. 2001 Nov 15; 33(10):1654-60.
Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance".
Getting smarter--the toxicity of undertreated HIV infection. N Engl J Med. 2006 Nov 30; 355(22):2359-61.
Getting smarter--the toxicity of undertreated HIV infection.
Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, Antin JH, Baden LR
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood. 2007 Jul 15; 110(2):490-500.
Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis.
Fungal brain infections. Curr Opin Neurol. 2008 Jun; 21(3):347-52.
Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009. Antimicrob Agents Chemother. 2011 Nov; 55(11):5018-21.
Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009.
Expanding the Donor Pool With Use of Hepatitis C Infected Hearts. Circ Heart Fail. 2018 12; 11(12):e005656.
Expanding the Donor Pool With Use of Hepatitis C Infected Hearts.
Alexander JP, Baden L, Pallansch MA, Anderson LJ
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis. 1994 Apr; 169(4):905-8.
Enterovirus 71 infections and neurologic disease--United States, 1977-1991.
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004 Feb 26; 350(9):950-2.
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR
Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis. 2005 Jul 01; 41(1):e5-8.
Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Prophylactic antimicrobial agents and the importance of fitness. N Engl J Med. 2005 Sep 08; 353(10):1052-4.
Prophylactic antimicrobial agents and the importance of fitness.
Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol. 2010 Apr; 48(4):1255-60.
Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis.
Cooper CJ, Metch B, Dragavon J, Coombs RW, Baden LR
Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients. JAMA. 2010 Jul 21; 304(3):275-83.
Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
Pasquini MC, Devine S, Mendizabal A, Baden LR, Wingard JR, Lazarus HM, Appelbaum FR, Keever-Taylor CA, Horowitz MM, Carter S, O'Reilly RJ, Soiffer RJ
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. J Clin Oncol. 2012 Sep 10; 30(26):3194-201.
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.
Cheng MP, Kusztos AE, Bold TD, Ho VT, Glotzbecker BE, Hsieh C, Baker MA, Baden LR, Hammond SP, Marty FM
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation. Clin Infect Dis. 2019 08 16; 69(5):869-872.
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell Transplantation.
Needed: Antimicrobial Development. N Engl J Med. 2019 02 21; 380(8):783-785.
Woolley AE, Singh SK, Goldberg HJ, Mallidi HR, Givertz MM, Mehra MR, Coppolino A, Kusztos AE, Johnson ME, Chen K, Haddad EA, Fanikos J, Harrington DP, Camp PC, Baden LR
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients. N Engl J Med. 2019 04 25; 380(17):1606-1617.
Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
Baumrin E, Cheng MP, Kanjilal S, Ho VT, Issa NC, Baden LR
Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis. Biol Blood Marrow Transplant. 2019 08; 25(8):1642-1647.
Severe Herpes Zoster Requiring Intravenous Antiviral Treatment in Allogeneic Hematopoietic Cell Transplantation Recipients on Standard Acyclovir Prophylaxis.
Harvard T.H. Chan School of Public Health
William Bosworth Castle Professor of Medicine
Cohen YZ, Butler AL, Millard K, Witmer-Pack M, Levin R, Unson-O'Brien C, Patel R, Shimeliovich I, Lorenzi JCC, Horowitz J, Walsh SR, Lin S, Weiner JA, Tse A, Sato A, Bennett C, Mayer B, Seaton KE, Yates NL, Baden LR, deCamp AC, Ackerman ME, Seaman MS, Tomaras GD, Nussenzweig MC, Caskey M
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study. PLoS One. 2019; 14(8):e0219142.
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study.
Heart and Lung Transplants from HCV-Infected Donors. Reply. N Engl J Med. 2019 09 05; 381(10):989.
Heart and Lung Transplants from HCV-Infected Donors. Reply.
Is ex-vivo viral eradication possible? Lancet Respir Med. 2020 02; 8(2):132-133.
Kallas EG, Grunenberg NA, Yu C, Manso B, Pantaleo G, Casapia M, Baden LR, Valencia J, Sobieszczyk M, Van Tieu H, Allen M, Hural J, Graham BS, Kublin J, Gilbert PB, Corey L, Goepfert PA, McElrath MJ, Johnson RP, Huang Y, Frahm N
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial. Sci Transl Med. 2019 11 20; 11(519).
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
Rubin EJ, Baden LR, Morrissey S, Campion EW
Medical Journals and the 2019-nCoV Outbreak. N Engl J Med. 2020 02 27; 382(9):866.
Medical Journals and the 2019-nCoV Outbreak.
Aldoss I, La Rosa C, Baden LR, Longmate J, Ariza-Heredia EJ, Rida WN, Lingaraju CR, Zhou Q, Martinez J, Kaltcheva T, Dagis A, Hardwick N, Issa NC, Farol L, Nademanee A, Al Malki MM, Forman S, Nakamura R, Diamond DJ
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial. Ann Intern Med. 2020 03 03; 172(5):306-316.
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.
Audio Interview: Preparing for the Spread of Covid-19. N Engl J Med. 2020 02 27; 382(9):e18.
Audio Interview: Preparing for the Spread of Covid-19.
Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19. N Engl J Med. 2020 03 05; 382(10):e19.
Audio Interview: What Clinicians Need to Know in Diagnosing and Treating Covid-19.
Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients. N Engl J Med. 2020 03 12; 382(11):e25.
Audio Interview: Making Decisions about Covid-19 Testing and Treatment for Your Patients.
Audio Interview: New Research on Possible Treatments for Covid-19. N Engl J Med. 2020 03 19; 382(12):e30.
Audio Interview: New Research on Possible Treatments for Covid-19.
Covid-19 - The Search for Effective Therapy. N Engl J Med. 2020 05 07; 382(19):1851-1852.
Covid-19 - The Search for Effective Therapy.
Woolley AE, Piechura LM, Goldberg HJ, Singh SK, Coppolino A, Baden LR, Mallidi HR
The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes. Ann Cardiothorac Surg. 2020 Jan; 9(1):42-48.
The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes.
Audio Interview: Practical Measures to Help Prevent Covid-19. N Engl J Med. 2020 Mar 26; 382(13):e32.
Audio Interview: Practical Measures to Help Prevent Covid-19.
Audio Interview: Lessons from Covid-19 Hotspots. N Engl J Med. 2020 04 02; 382(14):e35.
Audio Interview: Lessons from Covid-19 Hotspots.
Audio Interview: Emerging Tools in the Fight against Covid-19. N Engl J Med. 2020 Apr 09; 382(15):e39.
Audio Interview: Emerging Tools in the Fight against Covid-19.
Audio Interview: Approaches to Covid-19 Vaccines and Antivirals. N Engl J Med. 2020 04 23; 382(16):e58.
Audio Interview: Approaches to Covid-19 Vaccines and Antivirals.
Audio Interview: Caring for Patients with Covid-19. N Engl J Med. 2020 Apr 16; 382(16):e50.
Audio Interview: Caring for Patients with Covid-19.
Audio Interview: Loosening Covid-19 Restrictions. N Engl J Med. 2020 04 30; 382(18):e67.
Audio Interview: Loosening Covid-19 Restrictions.
Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, Chatham W, Cohen S, Costenbader K, Gravallese EM, Kalil AC, Weinblatt ME, Winthrop K, Mudano AS, Turner A, Saag KG
Arthritis & rheumatology (Hoboken, N.J.)
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1. Arthritis Rheumatol. 2020 08; 72(8):1241-1251.
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O'Horo JC, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Clin Infect Dis. 2020 Apr 27.
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Rubin EJ, Harrington DP, Hogan JW, Gatsonis C, Baden LR, Hamel MB
The Urgency of Care during the Covid-19 Pandemic - Learning as We Go. N Engl J Med. 2020 06 18; 382(25):2461-2462.
The Urgency of Care during the Covid-19 Pandemic - Learning as We Go.
Audio Interview: Studying Potential Covid-19 Therapies. N Engl J Med. 2020 05 07; 382(19):e72.
Audio Interview: Studying Potential Covid-19 Therapies.
Audio Interview: Finding Reliable Information about Covid-19. N Engl J Med. 2020 05 14; 382(20):e81.
Audio Interview: Finding Reliable Information about Covid-19.
Audio Interview: Capitalizing on Immune Responses to Covid-19. N Engl J Med. 2020 05 21; 382(21):e93.
Audio Interview: Capitalizing on Immune Responses to Covid-19.
Audio Interview: New Data on Remdesivir in Covid-19. N Engl J Med. 2020 05 28; 382(22):e94.
Audio Interview: New Data on Remdesivir in Covid-19.
Audio Interview: Diagnosis and Early Treatment of Covid-19. N Engl J Med. 2020 06 04; 382(23):e103.
Audio Interview: Diagnosis and Early Treatment of Covid-19.
Rubin EJ, Baden LR, Evans M, Morrissey S
Audio Interview: The Impact of Covid-19 on Minority Communities. N Engl J Med. 2020 06 11; 382(24):e111.
Audio Interview: The Impact of Covid-19 on Minority Communities.
Audio Interview: A Look at SARS-CoV-2 Transmission. N Engl J Med. 2020 06 18; 382(25):e112.
Audio Interview: A Look at SARS-CoV-2 Transmission.
Audio Interview: The Challenges of Safe Reopening. N Engl J Med. 2020 06 25; 382(26):e113.
Audio Interview: The Challenges of Safe Reopening.
Audio Interview: A Covid-19-Related Syndrome in Children. N Engl J Med. 2020 07 02; 383(1):e10.
Audio Interview: A Covid-19-Related Syndrome in Children.
Nilles EJ, Karlson EW, Norman M, Gilboa T, Fischinger S, Atyeo C, Zhou G, Bennett CL, Tolan NV, Oganezova K, Walt DR, Alter G, Simmons DP, Schur P, Jarolim P, Baden LR
medRxiv : the preprint server for health sciences
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2. medRxiv. 2020 Jun 26.
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2.
Audio Interview: Acute Lung Injury in Covid-19. N Engl J Med. 2020 07 09; 383(2):e32.
Audio Interview: Acute Lung Injury in Covid-19.
Audio Interview: Covid-19 Vaccine Development. N Engl J Med. 2020 07 16; 383(3):e40.
Audio Interview: Covid-19 Vaccine Development.
Audio Interview: Dexamethasone and Covid-19. N Engl J Med. 2020 07 23; 383(4):e52.
Audio Interview: Dexamethasone and Covid-19.
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2. Arthritis Rheumatol. 2020 09; 72(9):e1-e12.
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 2.
Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot. N Engl J Med. 2020 07 30; 383(5):e57.
Audio Interview: New SARS-CoV-2 Vaccine Results, with Peter Piot.
Snarr BD, St-Pierre G, Ralph B, Lehoux M, Sato Y, Rancourt A, Takazono T, Baistrocchi SR, Corsini R, Cheng MP, Sugrue M, Baden LR, Izumikawa K, Mukae H, Wingard JR, King IL, Divangahi M, Satoh MS, Yipp BG, Sato S, Sheppard DC
Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection. PLoS Pathog. 2020 08; 16(8):e1008741.
Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection.
Rubin EJ, Baden LR, Epstein A, Morrissey S
Audio Interview: The Impact of Covid-19 on Patients with Other Diseases, with Arnold Epstein. N Engl J Med. 2020 08 06; 383(6):e62.
Audio Interview: The Impact of Covid-19 on Patients with Other Diseases, with Arnold Epstein.
Audio Interview: Building a Successful Public Health Response to Covid-19. N Engl J Med. 2020 08 13; 383(7):e67.
Audio Interview: Building a Successful Public Health Response to Covid-19.
Audio Interview: Covid-19 and Contact Tracing. N Engl J Med. 2020 08 20; 383(8):e73.
Audio Interview: Covid-19 and Contact Tracing.
Roy V, Fischinger S, Atyeo C, Slein M, Loos C, Balazs A, Luedemann C, Astudillo MG, Yang D, Wesemann DR, Charles R, Lafrate AJ, Feldman J, Hauser B, Caradonna T, Miller TE, Murali MR, Baden L, Nilles E, Ryan E, Lauffenburger D, Beltran WG, Alter G
SARS-CoV-2-specific ELISA development. J Immunol Methods. 2020 Sep - Oct; 484-485:112832.
Audio Interview: Operation Warp Speed and Covid-19. N Engl J Med. 2020 08 27; 383(9):e79.
Audio Interview: Operation Warp Speed and Covid-19.
Audio Interview: Understanding Antibody Testing in Covid-19. N Engl J Med. 2020 09 03; 383(10):e85.
Audio Interview: Understanding Antibody Testing in Covid-19.
Audio Interview: Operation Warp Speed and Covid-19 Therapeutics. N Engl J Med. 2020 09 17; 383(12):e92.
Audio Interview: Operation Warp Speed and Covid-19 Therapeutics.
Yue H, Nowak RP, Overwijn D, Payne NC, Fischinger S, Atyeo C, Baden LR, Nilles EJ, Karlson EW, Yu XG, Li JZ, Alter G, Mazitschek R, Fischer ES
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma. medRxiv. 2020 Sep 03.
Rapid 'mix and read' assay for scalable detection of SARS-CoV-2 antibodies in patient plasma.
Audio Interview: Guidelines for Covid-19 Vaccine Deployment. N Engl J Med. 2020 09 10; 383(11):e88.
Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
Audio Interview: Eight Months of Action and Inaction against Covid-19. N Engl J Med. 2020 09 24; 383(13):e95.
Audio Interview: Eight Months of Action and Inaction against Covid-19.
Baden LR, Solomon CG, Greene MF, D'Agostino RB, Harrington D
The FDA and the Importance of Trust. N Engl J Med. 2020 12 31; 383(27):e148.
Audio Interview: Covid-19 Testing and the Individual Physician. N Engl J Med. 2020 Oct 01; 383(14):e99.
Audio Interview: Covid-19 Testing and the Individual Physician.
Audio Interview: Covid-19 and the President. N Engl J Med. 2020 10 08; 383(15):e104.
Audio Interview: Covid-19 and the President.
Baden LR, Stieh DJ, Sarnecki M, Walsh SR, Tomaras GD, Kublin JG, McElrath MJ, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert P, Edupuganti S, Karita E, Langedijk JP, Wegmann F, Corey L, Pau MG, Barouch DH, Schuitemaker H, Tomaka F
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study. Lancet HIV. 2020 10; 7(10):e688-e698.
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study.
Audio Interview: Vaccinology and Covid-19. N Engl J Med. 2020 10 15; 383(16):e109.
Audio Interview: Vaccinology and Covid-19.
Audio Interview: Tocilizumab and Covid-19. N Engl J Med. 2020 Oct 22; 383(17):e114.
Audio Interview: Tocilizumab and Covid-19.
Fajnzylber J, Regan J, Coxen K, Corry H, Wong C, Rosenthal A, Worrall D, Giguel F, Piechocka-Trocha A, Atyeo C, Fischinger S, Chan A, Flaherty KT, Hall K, Dougan M, Ryan ET, Gillespie E, Chishti R, Li Y, Jilg N, Hanidziar D, Baron RM, Baden L, Tsibris AM, Armstrong KA, Kuritzkes DR, Alter G, Walker BD, Yu X, Li JZ
SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020 10 30; 11(1):5493.
SARS-CoV-2 viral load is associated with increased disease severity and mortality.
Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, Solomon IH, Kuo HH, Boucau J, Bowman K, Adhikari UD, Winkler ML, Mueller AA, Hsu TY, Desjardins M, Baden LR, Chan BT, Walker BD, Lichterfeld M, Brigl M, Kwon DS, Kanjilal S, Richardson ET, Jonsson AH, Alter G, Barczak AK, Hanage WP, Yu XG, Gaiha GD, Seaman MS, Cernadas M, Li JZ
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N Engl J Med. 2020 12 03; 383(23):2291-2293.
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host.
Audio Interview: A New Monoclonal Antibody for Covid-19. N Engl J Med. 2020 Oct 29; 383(18):e117.
Audio Interview: A New Monoclonal Antibody for Covid-19.
Rubin EJ, Baden LR, Woodcock J, Morrissey S
Audio Interview: An Update from Operation Warp Speed. N Engl J Med. 2020 Nov 12; 383(20):e127.
Audio Interview: An Update from Operation Warp Speed.
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today. N Engl J Med. 2020 11 05; 383(19):e123.
Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
Rubin EJ, Baden LR, Haug CJ, Morrissey S
Audio Interview: Covid-19 in Europe and New Information on Vaccines. N Engl J Med. 2020 Nov 19; 383(21):e134.
Audio Interview: Covid-19 in Europe and New Information on Vaccines.
Zhao J, Gabriel E, Norda R, Höglund P, Baden L, Diedrich BA, Marits P, Enoksson SL, Gansner JM, Kaufman R, Dickman PW, Edgren G
Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study. Transfusion. 2021 02; 61(2):464-473.
Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study.
Audio Interview: New Studies of Covid-19 Transmission. N Engl J Med. 2020 11 26; 383(22):e138.
Audio Interview: New Studies of Covid-19 Transmission.
Audio Interview: Caring for Hospitalized Patients with Covid-19. N Engl J Med. 2020 12 03; 383(23):e140.
Audio Interview: Caring for Hospitalized Patients with Covid-19.
A Large, Simple Trial Leading to Complex Questions. N Engl J Med. 2021 02 11; 384(6):576-577.
A Large, Simple Trial Leading to Complex Questions.
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3. Arthritis Rheumatol. 2021 02; 73(2):e1-e12.
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.
Li Y, Regan J, Fajnzylber J, Coxen K, Corry H, Wong C, Rosenthal A, Atyeo C, Fischinger S, Gillespie E, Chishti R, Baden L, Yu XG, Alter G, Kim A, Li JZ
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19. Hepatol Commun. 2020 Dec 10.
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19.
Rubin EJ, Baden LR, Barocas JA, Morrissey S
Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations. N Engl J Med. 2020 12 10; 383(24):e143.
Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations.
Audio Interview: Covid-19 Vaccine Fundamentals. N Engl J Med. 2020 12 17; 383(25):e146.
Audio Interview: Covid-19 Vaccine Fundamentals.
Follmann D, Fintzi J, Fay MP, Janes HE, Baden L, Sahly HE, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials. medRxiv. 2020 Dec 14.
Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 02 04; 384(5):403-416.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Audio Interview: A Look at Covid-19 Prevention and Care in 2020. N Engl J Med. 2020 12 31; 383(27):e147.
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout. N Engl J Med. 2021 01 07; 384(1):e13.
Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
Rubin EJ, Baden LR, Nottage K, O'Connell J, Wong G, Morrissey S
Audio Interview: An International Look at Covid-19. N Engl J Med. 2021 01 21; 384(3):e19.
Audio Interview: An International Look at Covid-19.
Rubin EJ, Baden LR, Abdool Karim SS, Morrissey S
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant. N Engl J Med. 2021 Jan 14; 384(2):e14.
Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
Rubin EJ, Baden LR, Fauci AS, Morrissey S
Audio Interview: A Covid-19 Conversation with Anthony Fauci. N Engl J Med. 2021 01 28; 384(4):e22.
Audio Interview: A Covid-19 Conversation with Anthony Fauci.
Oganezova K, Fontana-Martinez EJ, Gothing JA, Pandit A, Kwara E, Yanosick K, Dragavon J, Goecker EA, Maenza J, Espy N, Tomaka F, Lavreys L, Allen M, D'Souza P, Hural J, Coombs RW, Dolin R, Seaman MS, Walsh SR, Baden LR
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees. Open Forum Infect Dis. 2021 Jan; 8(1):ofaa606.
Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.
Analysis of Exhaled Volatiles for the Diagnosis
Rubin EJ, Baden LR, Northam RS, Morrissey S
Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam. N Engl J Med. 2021 Feb 04; 384(5):e25.
Audio Interview: Covid-19 and the States - A Conversation with Ralph Northam.
Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing? N Engl J Med. 2021 02 11; 384(6):e32.
Audio Interview: Does Vaccination Mean the End of Masking and Social Distancing?
Bartsch YC, Wang C, Zohar T, Fischinger S, Atyeo C, Burke JS, Kang J, Edlow AG, Fasano A, Baden LR, Nilles EJ, Woolley AE, Karlson EW, Hopke AR, Irimia D, Fischer ES, Ryan ET, Charles RC, Julg BD, Lauffenburger DA, Yonker LM, Alter G
Humoral signatures of protective and pathological SARS-CoV-2 infection in children. Nat Med. 2021 03; 27(3):454-462.
Humoral signatures of protective and pathological SARS-CoV-2 infection in children.
Rubin EJ, Baden LR, Farrar JJ, Morrissey S
Audio Interview: Viral Variants and Covid-19. N Engl J Med. 2021 Feb 18; 384(7):e38.
Audio Interview: Viral Variants and Covid-19.
Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination. N Engl J Med. 2021 02 25; 384(8):e40.
Audio Interview: The Real-World Effectiveness of Covid-19 Vaccination.
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup. N Engl J Med. 2021 04 22; 384(16):1564-1565.
Interleukin-6 Receptor Inhibition in Covid-19 - Cooling the Inflammatory Soup.
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment. N Engl J Med. 2021 Mar 04; 384(9):e46.
Audio Interview: A New SARS-CoV-2 Vaccine and a New Look at Treatment.
Rubin EJ, Baden LR, Abraham J, Morrissey S
Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2. N Engl J Med. 2021 03 11; 384(10):e48.
Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
Baumrin E, Izaguirre NE, Bausk B, Feeley MM, Bay CP, Yang Q, Ho VT, Baden LR, Issa NC
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation. Blood Adv. 2021 03 23; 5(6):1585-1593.
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantation.
Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. N Engl J Med. 2021 03 18; 384(11):1003-1014.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses. N Engl J Med. 2021 03 18; 384(11):e53.
Audio Interview: Efficacy of Current Covid-19 Vaccines against Variant Viruses.
Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Sadun RE, Turner AS, Williams EA, Mikuls TR
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1. Arthritis Rheumatol. 2021 07; 73(7):1093-1107.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1.
Rubin EJ, Baden LR, Brandt AM, Morrissey S
Audio Interview: What Earlier Epidemics Teach Us about Covid-19. N Engl J Med. 2021 03 25; 384(12):e55.
Audio Interview: What Earlier Epidemics Teach Us about Covid-19.
Audio Interview: Antibody Responses to Natural Infection and Vaccination. N Engl J Med. 2021 04 08; 384(14):e65.
Audio Interview: Antibody Responses to Natural Infection and Vaccination.
Rubin EJ, Baden LR, Del Rio C, Akusobi C, Morrissey S
Audio Interview: Delivering Covid-19 Vaccines to Minority Communities. N Engl J Med. 2021 04 01; 384(13):e60.
Audio Interview: Delivering Covid-19 Vaccines to Minority Communities.
Follmann D, Fintzi J, Fay MP, Janes HE, Baden LR, El Sahly HM, Fleming TR, Mehrotra DV, Carpp LN, Juraska M, Benkeser D, Donnell D, Fong Y, Han S, Hirsch I, Huang Y, Huang Y, Hyrien O, Luedtke A, Carone M, Nason M, Vandebosch A, Zhou H, Cho I, Gabriel E, Kublin JG, Cohen MS, Corey L, Gilbert PB, Neuzil KM
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated. Ann Intern Med. 2021 08; 174(8):1118-1125.
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen CP, Chen TC, Cheng SH, Cheng CY, Chung WS, Cohen YZ, Cowan LN, Dalgard O, de Almeida E Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang YW, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo CY, Le T, Lin YC, Lin WP, Lin TH, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O'Brien SM, Okeke NL, Perez L, Perez-Padilla R, Perrin L, Remigio-Luna A, Rivera-Martinez NE, Rockhold FW, Rodriguez-Llamazares S, Rolfe R, Rosa R, Røsjø H, Sampaio VS, Seto TB, Shahzad M, Soliman S, Stout JE, Thirion-Romero I, Troxel AB, Tseng TY, Turner NA, Ulrich RJ, Walsh SR, Webb SA, Weehuizen JM, Velinova M, Wong HL, Wrenn R, Zampieri FG, Zhong W, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 04 15; 12(1):2349.
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions. N Engl J Med. 2021 04 29; 384(17):e77.
Audio Interview: Advice for Clinicians on Covid-19 Vaccines and Social Restrictions.
Audio Interview: Vaccine Successes and Vaccine Adverse Events. N Engl J Med. 2021 Apr 15; 384(15):e70.
Audio Interview: Vaccine Successes and Vaccine Adverse Events.
Rubin EJ, Baden LR, Walensky RP, Morrissey S
Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky. N Engl J Med. 2021 04 22; 384(16):e73.
Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
Rubin EJ, Baden LR, Udwadia ZF, Morrissey S
Audio Interview: India's Covid-19 Crisis. N Engl J Med. 2021 May 06; 384(18):e84.
Audio Interview: India's Covid-19 Crisis.
Mysore V, Cullere X, Settles ML, Ji X, Kattan MW, Desjardins M, Durbin-Johnson B, Gilboa T, Baden LR, Walt DR, Lichtman A, Jehi L, Mayadas TN
bioRxiv : the preprint server for biology
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens. bioRxiv. 2021 May 04.
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens.
Rubin EJ, Baden LR, Drazen JM, Taichman DB, Morrissey S
Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research. N Engl J Med. 2021 May 20; 384(20):e89.
Audio Interview: Vaccination in Nursing Homes and New Pulmonary/Critical Care Research.
Ogata AF, Cheng CA, Desjardins M, Senussi Y, Sherman AC, Powell M, Novack L, Von S, Li X, Baden LR, Walt DR
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients. Clin Infect Dis. 2022 03 01; 74(4):715-718.
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients.
Scheid JF, Barnes CO, Eraslan B, Hudak A, Keeffe JR, Cosimi LA, Brown EM, Muecksch F, Weisblum Y, Zhang S, Delorey T, Woolley AE, Ghantous F, Park SM, Phillips D, Tusi B, Huey-Tubman KE, Cohen AA, Gnanapragasam PNP, Rzasa K, Hatziioanno T, Durney MA, Gu X, Tada T, Landau NR, West AP, Rozenblatt-Rosen O, Seaman MS, Baden LR, Graham DB, Deguine J, Bieniasz PD, Regev A, Hung D, Bjorkman PJ, Xavier RJ
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV. Cell. 2021 06 10; 184(12):3205-3221.e24.
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV.
Rubin EJ, Baden LR, Gray GE, Morrissey S
Audio Interview: Vaccination and Variants in the U.S. and South Africa. N Engl J Med. 2021 05 13; 384(19):e85.
Audio Interview: Vaccination and Variants in the U.S. and South Africa.
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 May 14; 12(1):3001.
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
Nanishi E, Borriello F, O'Meara TR, McGrath ME, Saito Y, Haupt RE, Seo HS, van Haren SD, Brook B, Chen J, Diray-Arce J, Doss-Gollin S, Leon M, Chew K, Menon M, Song K, Xu AZ, Caradonna TM, Feldman J, Hauser BM, Schmidt AG, Sherman AC, Baden LR, Ernst RK, Dillen C, Weston SM, Johnson RM, Hammond HL, Mayer R, Burke A, Bottazzi ME, Hotez PJ, Strych U, Chang A, Yu J, Barouch DH, Dhe-Paganon S, Zanoni I, Ozonoff A, Frieman MB, Levy O, Dowling DJ
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity. bioRxiv. 2021 May 21.
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity.
Audio Interview: Protecting the Immunosuppressed against Covid-19. N Engl J Med. 2021 May 27; 384(21):e88.
Audio Interview: Protecting the Immunosuppressed against Covid-19.
Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Gravallese EM, Bass AR, Calabrese C, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, Mikuls TR
Audio Interview: Vaccinating Children. N Engl J Med. 2021 06 03; 384(22):e103.
Rubin EJ, Baden LR, Longo DL, Morrissey S
Audio Interview: Treating Complications of Covid Vaccination. N Engl J Med. 2021 06 10; 384(23):e107.
Audio Interview: Treating Complications of Covid Vaccination.
Rubin EJ, Baden LR, Ingelfinger JR, Morrissey S
Audio Interview: Covid-19 in Children. N Engl J Med. 2021 06 17; 384(24):e108.
Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, Calabrese C, Gravallese EM, Harpaz R, Kroger A, Sadun RE, Turner AS, Williams EA, Mikuls TR
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2. Arthritis Rheumatol. 2021 08; 73(8):e30-e45.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2.
Hahn G, Wu CM, Lee S, Lutz SM, Khurana S, Baden LR, Haneuse S, Qiao D, Hecker J, DeMeo DL, Tanzi RE, Choudhary MC, Etemad B, Mohammadi A, Esmaeilzadeh E, Cho MH, Li JZ, Randolph AG, Laird NM, Weiss ST, Silverman EK, Ribbeck K, Lange C
Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain. Genet Epidemiol. 2021 10; 45(7):685-693.
Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.
Nilles EJ, Karlson EW, Norman M, Gilboa T, Fischinger S, Atyeo C, Zhou G, Bennett CL, Tolan NV, Oganezova K, Walt DR, Alter G, Simmons DP, Schur P, Jarolim P, Woolley AE, Baden LR
The journal of applied laboratory medicine
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. J Appl Lab Med. 2021 11 01; 6(6):1561-1570.
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2.
Astronomo RD, Lemos MP, Narpala SR, Czartoski J, Fleming LB, Seaton KE, Prabhakaran M, Huang Y, Lu Y, Westerberg K, Zhang L, Gross MK, Hural J, Tieu HV, Baden LR, Hammer S, Frank I, Ochsenbauer C, Grunenberg N, Ledgerwood JE, Mayer K, Tomaras G, McDermott AB, McElrath MJ
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. J Clin Invest. 2021 08 16; 131(16).
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
Audio Interview: A New mRNA Vaccine. N Engl J Med. 2021 Jun 24; 384(25):e109.
Huang Y, Seaton KE, Casapia M, Polakowski L, De Rosa SC, Cohen K, Yu C, Elizaga M, Paez C, Miner MD, Kelley CF, Maenza J, Keefer M, Lama JR, Sobieszczyk M, Buchbinder S, Baden LR, Lee C, Gulati V, Sinangil F, Montefiori D, McElrath MJ, Tomaras GD, Robinson HL, Goepfert P
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period. Vaccine. 2021 07 30; 39(33):4641-4650.
AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.
Audio Interview: How Well Are Covid-19 Vaccines Working? N Engl J Med. 2021 07 08; 385(2):e15.
Audio Interview: How Well Are Covid-19 Vaccines Working?
Audio Interview: Another New Covid-19 Vaccine. N Engl J Med. 2021 07 01; 385(1):e13.
Audio Interview: Another New Covid-19 Vaccine.
Audio Interview: Monoclonal Antibodies and Vaccine Boosts. N Engl J Med. 2021 07 15; 385(3):e18.
Audio Interview: Monoclonal Antibodies and Vaccine Boosts.
Rubin EJ, Baden LR, Armstrong KA, Morrissey S
Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty. N Engl J Med. 2021 07 22; 385(4):e21.
Audio Interview: The Impact of Covid-19 on Trainees and Junior Faculty.
Audio Interview: Looking Back and Looking Forward — Part 1. N Engl J Med. 2021 Jul 29; 385(5):e24.
Audio Interview: Looking Back and Looking Forward — Part 1.
Audio Interview: Looking Back and Looking Forward - Part 2. N Engl J Med. 2021 08 05; 385(6):e25.
Audio Interview: Looking Back and Looking Forward - Part 2.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3. Arthritis Rheumatol. 2021 10; 73(10):e60-e75.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.
North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination. Clin Infect Dis. 2022 04 09; 74(7):1275-1278.
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.
Audio Interview: Monoclonal Antibodies and Booster Shots. N Engl J Med. 2021 Aug 12; 385(7):e29.
Audio Interview: Monoclonal Antibodies and Booster Shots.
Crombie JL, Sherman AC, Cheng CA, Ryan CE, Zon R, Desjardins M, Baker P, McDonough M, Izaguirre N, Bausk B, Krauss J, Gilboa T, Senussi Y, Walt DR, Davids MS, Brown JR, Armand P, Baden LR, Issa N
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies. Blood Adv. 2021 08 24; 5(16):3062-3065.
Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies.
Mysore V, Cullere X, Settles ML, Ji X, Kattan MW, Desjardins M, Durbin-Johnson B, Gilboa T, Baden LR, Walt DR, Lichtman AH, Jehi L, Mayadas TN
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens. Med. 2021 09 10; 2(9):1050-1071.e7.
Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens.
Audio Interview: Aspects of Covid-19 Immunity. N Engl J Med. 2021 08 19; 385(8):e31.
Audio Interview: Aspects of Covid-19 Immunity.
Gilbert PB, Montefiori DC, McDermott A, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi N, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Kutner M, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. medRxiv. 2021 Aug 15.
Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Regan J, Flynn JP, Rosenthal A, Jordan H, Li Y, Chishti R, Giguel F, Corry H, Coxen K, Fajnzylber J, Gillespie E, Kuritzkes DR, Hacohen N, Goldberg MB, Filbin MR, Yu XG, Baden L, Ribeiro RM, Perelson AS, Conway JM, Li JZ
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019. Open Forum Infect Dis. 2021 Aug; 8(8):ofab153.
Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019.
Audio Interview: Assessing Vaccine Safety. N Engl J Med. 2021 08 26; 385(9):e37.
Audio Interview: Assessing Vaccine Safety.
Audio Interview: A New Round of Rising Covid-19 Numbers. N Engl J Med. 2021 09 02; 385(10):e41.
Audio Interview: A New Round of Rising Covid-19 Numbers.
Audio Interview: Protecting against Severe Disease and Transmission. N Engl J Med. 2021 Sep 09; 385(11):e44.
Audio Interview: Protecting against Severe Disease and Transmission.
Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters. N Engl J Med. 2021 Sep 16; 385(12):e48.
Audio Interview: New Evidence on SARS-CoV-2 Vaccine Boosters.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 04; 385(19):1774-1785.
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
Audio Interview: Vaccine Efficacy and Boosters in Covid-19. N Engl J Med. 2021 09 23; 385(13):e54.
Audio Interview: Vaccine Efficacy and Boosters in Covid-19.
Liver Fibrosis Index FIB-4 Is Associated With Mortality in COVID-19. Hepatol Commun. 2021 03; 5(3):434-445.
Rubin EJ, Baden LR, Tofel R, Morrissey S
Audio Interview: Covid-19 and the Media. N Engl J Med. 2021 09 30; 385(14):e59.
Audio Interview: Covid-19 and the Media.
Baden LR, El Sahly HM, Essink B, Follmann D, Neuzil KM, August A, Clouting H, Fortier G, Deng W, Han S, Zhao X, Leav B, Talarico C, Girard B, Paila YD, Tomassini JE, Schödel F, Pajon R, Zhou H, Das R, Miller J
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge. medRxiv. 2021 Sep 22.
Covid-19 in the Phase 3 Trial of mRNA-1273 During the Delta-variant Surge.
Audio Interview: Are Covid-19 Vaccine Boosters Necessary? N Engl J Med. 2021 Oct 07; 385(15):e63.
Audio Interview: Are Covid-19 Vaccine Boosters Necessary?
Wingard JR, Alexander BD, Baden LR, Chen M, Sugrue MW, Leather HL, Caliendo AM, Clancy CJ, Denning DW, Marty FM, Nguyen MH, Wheat LJ, Logan BR, Horowitz MM, Marr KA
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials? Open Forum Infect Dis. 2021 Oct; 8(10):ofab441.
Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?
Audio Interview: Reporting on Covid-19. N Engl J Med. 2021 Oct 14; 385(16):e66.
Bhimraj A, Morgan RL, Shumaker AH, Baden L, Cheng VC, Edwards KM, Gandhi RT, Gallagher JC, Muller WJ, O'Horo JC, Shoham S, Wollins DS, Falck-Ytter Y
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel. Clin Infect Dis. 2022 05 03; 74(9):1691-1695.
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel.
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi RT, Gallagher JC, Muller WJ, O'Horo JC, Shoham S, Wollins DS, Falck-Ytter Y
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords. Clin Infect Dis. 2022 05 03; 74(9):1686-1690.
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords.
Audio Interview: A New Look at Covid-19 Vaccine Boosters. N Engl J Med. 2021 10 21; 385(17):e72.
Audio Interview: A New Look at Covid-19 Vaccine Boosters.
Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children. N Engl J Med. 2021 Oct 28; 385(18):e74.
Audio Interview: A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children.
Nanishi E, Borriello F, O'Meara TR, McGrath ME, Saito Y, Haupt RE, Seo HS, van Haren SD, Cavazzoni CB, Brook B, Barman S, Chen J, Diray-Arce J, Doss-Gollin S, De Leon M, Prevost-Reilly A, Chew K, Menon M, Song K, Xu AZ, Caradonna TM, Feldman J, Hauser BM, Schmidt AG, Sherman AC, Baden LR, Ernst RK, Dillen C, Weston SM, Johnson RM, Hammond HL, Mayer R, Burke A, Bottazzi ME, Hotez PJ, Strych U, Chang A, Yu J, Sage PT, Barouch DH, Dhe-Paganon S, Zanoni I, Ozonoff A, Frieman MB, Levy O, Dowling DJ
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice. Sci Transl Med. 2022 Jan 26; 14(629):eabj5305.
An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice.
Sherman AC, Desjardins M, Cheng CA, Bausk B, Izaguirre N, Zhou G, Krauss J, Tolan N, Walt DR, Soiffer R, Ho VT, Issa NC, Baden LR
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity. Clin Infect Dis. 2022 08 24; 75(1):e920-e923.
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic? N Engl J Med. 2021 11 04; 385(19):e78.
Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
Audio Interview: What's Gone Right in Our Battle against Covid-19. N Engl J Med. 2021 11 25; 385(22):e95.
Audio Interview: What's Gone Right in Our Battle against Covid-19.
Nabel KG, Clark SA, Shankar S, Pan J, Clark LE, Yang P, Coscia A, McKay LGA, Varnum HH, Brusic V, Tolan NV, Zhou G, Desjardins M, Turbett SE, Kanjilal S, Sherman AC, Dighe A, LaRocque RC, Ryan ET, Tylek C, Cohen-Solal JF, Darcy AT, Tavella D, Clabbers A, Fan Y, Griffiths A, Correia IR, Seagal J, Baden LR, Charles RC, Abraham J
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain. Science. 2022 01 21; 375(6578):eabl6251.
Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
Rubin EJ, Baden LR, Grinsztejn B, Morrissey S
Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children. N Engl J Med. 2021 Nov 11; 385(20):e79.
Audio Interview: Covid-19 in Brazil and New Evidence for Vaccinating Younger Children.
Gilbert PB, Montefiori DC, McDermott AB, Fong Y, Benkeser D, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Huynh C, Miller J, El Sahly HM, Baden LR, Baron M, De La Cruz L, Gay C, Kalams S, Kelley CF, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science. 2022 Jan 07; 375(6576):43-50.
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge. N Engl J Med. 2021 12 23; 385(26):2485-2487.
Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge.
Rubin EJ, Baden LR, Mello MM, Morrissey S
Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates. N Engl J Med. 2021 Nov 18; 385(21):e88.
Audio Interview: The Legal Basis for Covid-19 Restrictions and Mandates.
Campion SL, Brenna E, Thomson E, Fischer W, Ladell K, McLaren JE, Price DA, Frahm N, McElrath JM, Cohen KW, Maenza JR, Walsh SR, Baden LR, Haynes BF, Korber B, Borrow P, McMichael AJ
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial. J Clin Invest. 2021 12 01; 131(23).
Preexisting memory CD4+ T cells contribute to the primary response in an HIV-1 vaccine trial.
Audio Interview: Waning Immunity against SARS-CoV-2. N Engl J Med. 2021 12 09; 385(24):e99.
Audio Interview: Waning Immunity against SARS-CoV-2.
Finberg RW, Ashraf M, Julg B, Ayoade F, Marathe JG, Issa NC, Wang JP, Jaijakul S, Baden LR, Epstein C
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19. Open Forum Infect Dis. 2021 Dec; 8(12):ofab563.
US201 Study: A Phase 2, Randomized Proof-of-Concept Trial of Favipiravir for the Treatment of COVID-19.
Audio Interview: The Omicron Variant of SARS-CoV-2. N Engl J Med. 2021 Dec 02; 385(23):e96.
Audio Interview: The Omicron Variant of SARS-CoV-2.
Audio Interview: A Potential New Agent to Treat Covid-19. N Engl J Med. 2021 Dec 23; 385(26):e101.
Audio Interview: A Potential New Agent to Treat Covid-19.
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide? N Engl J Med. 2021 Dec 16; 385(25):e100.
Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
Desjardins M, Mitre X, Sherman AC, Walsh SR, Cheng MP, Kanjilal S, Ho VT, Baden LR, Issa NC
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant. Open Forum Infect Dis. 2021 Dec; 8(12):ofab504.
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell Transplant.
Audio Interview: Covid-19 Vaccination and the Omicron Variant. N Engl J Med. 2021 Dec 30; 385(27):e102.
Audio Interview: Covid-19 Vaccination and the Omicron Variant.
Weber B, Siddiqi H, Zhou G, Vieira J, Kim A, Rutherford H, Mitre X, Feeley M, Oganezova K, Varshney AS, Bhatt AS, Nauffal V, Atri DS, Blankstein R, Karlson EW, Di Carli M, Baden LR, Bhatt DL, Woolley AE
Journal of the American Heart Association
Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes. J Am Heart Assoc. 2022 01 04; 11(1):e022010.
Relationship Between Myocardial Injury During Index Hospitalization for SARS-CoV-2 Infection and Longer-Term Outcomes.
Rubin EJ, Baden LR, Drosten C, Morrissey S
Audio Interview: Covid-19 - The Outlook in Europe. N Engl J Med. 2022 01 06; 386(1):e9.
Audio Interview: Covid-19 - The Outlook in Europe.
Rubin EJ, Baden LR, Fineberg HV, Morrissey S
Audio Interview: Crushing the Covid-19 Curve. N Engl J Med. 2022 01 20; 386(3):e13.
Audio Interview: Crushing the Covid-19 Curve.
Audio Interview: Covid-19 Takeaways at Podcast 100. N Engl J Med. 2022 01 13; 386(2):e11.
Audio Interview: Covid-19 Takeaways at Podcast 100.
Audio Interview: Addressing the Omicron Variant of SARS-CoV-2. N Engl J Med. 2022 Jan 27; 386(4):e16.
Audio Interview: Addressing the Omicron Variant of SARS-CoV-2.
Pajon R, Doria-Rose NA, Shen X, Schmidt SD, O'Dell S, McDanal C, Feng W, Tong J, Eaton A, Maglinao M, Tang H, Manning KE, Edara VV, Lai L, Ellis M, Moore KM, Floyd K, Foster SL, Posavad CM, Atmar RL, Lyke KE, Zhou T, Wang L, Zhang Y, Gaudinski MR, Black WP, Gordon I, Guech M, Ledgerwood JE, Misasi JN, Widge A, Sullivan NJ, Roberts PC, Beigel JH, Korber B, Baden LR, El Sahly H, Chalkias S, Zhou H, Feng J, Girard B, Das R, Aunins A, Edwards DK, Suthar MS, Mascola JR, Montefiori DC
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination. N Engl J Med. 2022 03 17; 386(11):1088-1091.
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
Pajon R, Paila YD, Girard B, Dixon G, Kacena K, Baden LR, El Sahly HM, Essink B, Mullane KM, Frank I, Denhan D, Kerwin E, Zhao X, Ding B, Deng W, Tomassini JE, Zhou H, Leav B, Schödel F
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial. Nat Med. 2022 04; 28(4):823-830.
Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.
Rubin EJ, Baden LR, Rosen CJ, Morrissey S
Audio Interview: Studying Long Covid. N Engl J Med. 2022 02 03; 386(5):e20.
Audio Interview: Covid-19 as an Endemic Disease. N Engl J Med. 2022 Feb 10; 386(6):e21.
Audio Interview: Covid-19 as an Endemic Disease.
Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly. N Engl J Med. 2022 Mar 03; 386(9):e29.
Audio Interview: Using Our Covid-19 Experience to Develop Vaccines More Quickly.
Audio Interview: Effectiveness of Covid-19 Vaccination in Children. N Engl J Med. 2022 03 31; 386(13):e39.
Audio Interview: Effectiveness of Covid-19 Vaccination in Children.
Khan NH, Rouphael NG, Baden LR, Graciaa DS
Is the BCG Vaccine an Answer to Future Pandemic Preparedness? Vaccines (Basel). 2022 Jan 27; 10(2).
Is the BCG Vaccine an Answer to Future Pandemic Preparedness?
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection). Clin Lab Med. 2022 03; 42(1):111-128.
Vaccine-Induced Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and the Path to Accelerating Development (Determining a Correlate of Protection).
Audio Interview: Understanding the Omicron Variant of SARS-CoV-2. N Engl J Med. 2022 Feb 24; 386(8):e27.
Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
Audio Interview: Can We Make More Effective Covid-19 Vaccines? N Engl J Med. 2022 03 17; 386(11):e36.
Audio Interview: Can We Make More Effective Covid-19 Vaccines?
Audio Interview: A New Antiviral against Covid-19. N Engl J Med. 2022 02 17; 386(7):e25.
Audio Interview: A New Antiviral against Covid-19.
Rubin EJ, Baden LR, Hunter D, Morrissey S
Audio Interview: Making Covid-19 Vaccines Available around the World. N Engl J Med. 2022 Mar 10; 386(10):e31.
Audio Interview: Making Covid-19 Vaccines Available around the World.
The Potential of Intentional Drug Development. N Engl J Med. 2022 04 14; 386(15):1463-1464.
The Potential of Intentional Drug Development.
Eraslan B, Brown E, Benson M, Amir-Zilberstein L, Park SM, Tusi B, Pokatayev V, Hecht C, Pishesha N, Phillips D, Kim A, Zhang S, Gaca A, Ghantous F, Delorey T, Livny J, Baden L, Rozenblatt-Rosen O, Graham D, Regev A, Seaman M, Woolley A, Cosimi L, Hung D, Deguine J, Xavier R
Functional analyses and single cell immunoprofiling uncover sex-specific differences in SARS-CoV2 immune memory development. Res Sq. 2022 Mar 15.
Functional analyses and single cell immunoprofiling uncover sex-specific differences in SARS-CoV2 immune memory development.
Audio Interview: Covid-19: Why We Publish What We Do. N Engl J Med. 2022 03 24; 386(12):e38.
Audio Interview: Covid-19: Why We Publish What We Do.
Tolan NV, Sherman AC, Zhou G, Nabel KG, Desjardins M, Melanson S, Kanjilal S, Moheed S, Kupelian J, Kaufman RM, Ryan ET, LaRocque RC, Branda JA, Dighe AS, Abraham J, Baden LR, Charles RC, Turbett SE
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients. Microbiol Spectr. 2022 04 27; 10(2):e0021122.
The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients.
Hunter DJ, Abdool Karim SS, Baden LR, Farrar JJ, Hamel MB, Longo DL, Morrissey S, Rubin EJ
Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good. N Engl J Med. 2022 03 24; 386(12):1176-1179.
Addressing Vaccine Inequity - Covid-19 Vaccines as a Global Public Good.
Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic. Clin Infect Dis. 2022 08 15; 75(Suppl 1):S5-S10.
Coronavirus Disease 2019 Vaccine Trials (and Tribulations): How to Improve the Process of Clinical Trials in a Pandemic.
Audio Interview: Do We Need New Covid-19 Vaccines? N Engl J Med. 2022 05 05; 386(18):e52.
Audio Interview: Do We Need New Covid-19 Vaccines?
Little JS, Dedrick RM, Freeman KG, Cristinziano M, Smith BE, Benson CA, Jhaveri TA, Baden LR, Solomon DA, Hatfull GF
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection. Nat Commun. 2022 05 03; 13(1):2313.
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection.
Rubin EJ, Baden LR, Marrazzo JM, Morrissey S
Audio Interview: Communicating Covid-19 Science. N Engl J Med. 2022 04 28; 386(17):e53.
Audio Interview: Communicating Covid-19 Science.
Rubin EJ, Baden LR, Inglefinger JR, Morrissey S
Audio Interview: The Effects of Covid-19 on Children. N Engl J Med. 2022 Apr 21; 386(16):e51.
Audio Interview: The Effects of Covid-19 on Children.
Rubin EJ, Baden LR, Bloom BR, Morrissey S
Audio Interview: Do the Tobacco Wars Offer Any Lessons for the Vaccine Wars? N Engl J Med. 2022 04 14; 386(15):e48.
Audio Interview: Do the Tobacco Wars Offer Any Lessons for the Vaccine Wars?
Audio Interview: Do We Need a Fourth Dose of Covid Vaccine? N Engl J Med. 2022 04 07; 386(14):e45.
Audio Interview: Do We Need a Fourth Dose of Covid Vaccine?
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4. Arthritis Rheumatol. 2022 05; 74(5):e21-e36.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4.
Omicron - Decoupling Infection from Severe Disease. N Engl J Med. 2022 04 07; 386(14):1361-1362.
Omicron - Decoupling Infection from Severe Disease.
Audio Interview: What to Make of Covid-19 Hot Spots. N Engl J Med. 2022 05 19; 386(19):e63.
Audio Interview: What to Make of Covid-19 Hot Spots.
Little JS, Shapiro RM, Aleissa MM, Kim A, Chang JBP, Kubiak DW, Zhou G, Antin JH, Koreth J, Nikiforow S, Cutler CS, Romee R, Issa NC, Ho VT, Gooptu M, Soiffer RJ, Baden LR
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome. Transplant Cell Ther. 2022 08; 28(8):508.e1-508.e8.
Invasive Yeast Infection after Haploidentical Donor Hematopoietic Cell Transplantation Associated with Cytokine Release Syndrome.
El Sahly HM, Baden LR, Essink B, Montefiori D, McDermont A, Rupp R, Lewis M, Swaminathan S, Griffin C, Fragoso V, Miller VE, Girard B, Paila YD, Deng W, Tomassini JE, Paris R, Schödel F, Das R, August A, Leav B, Miller JM, Zhou H, Pajon R
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial. J Infect Dis. 2022 11 11; 226(10):1731-1742.
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial.
Rubin EJ, Baden LR, Lipsitch M, Morrissey S
Audio Interview: Forecasting the Future of Covid. N Engl J Med. 2022 05 12; 386(19):e58.
Audio Interview: Forecasting the Future of Covid.
Villalba JA, Hilburn CF, Garlin MA, Elliott GA, Li Y, Kunitoki K, Poli S, Alba GA, Madrigal E, Taso M, Price MC, Aviles AJ, Araujo-Medina M, Bonanno L, Boyraz B, Champion SN, Harris CK, Helland TL, Hutchison B, Jobbagy S, Marshall MS, Shepherd DJ, Barth JL, Hung YP, Ly A, Hariri LP, Turbett SE, Pierce VM, Branda JA, Rosenberg ES, Mendez-Pena J, Chebib I, Rosales IA, Smith RN, Miller MA, Rosas IO, Hardin CC, Baden LR, Medoff BD, Colvin RB, Little BP, Stone JR, Mino-Kenudson M, Shih AR
American journal of respiratory and critical care medicine
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2022 10 01; 206(7):857-873.
Vasculopathy and Increased Vascular Congestion in Fatal COVID-19 and Acute Respiratory Distress Syndrome.
Audio Interview: Waning Immunity against Covid-19. N Engl J Med. 2022 05 26; 386(21):e64.
Audio Interview: Waning Immunity against Covid-19.
Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Rostad CA, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Lee M, Nayak SU, Montefiori DC, Makowski M, Smith DJ, Roberts PC, Beigel JH
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. medRxiv. 2022 Jul 15.
SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.
Audio Interview: How Effective is Covid-19 Vaccination in Children? N Engl J Med. 2022 06 30; 386(26):e78.
Audio Interview: How Effective is Covid-19 Vaccination in Children?
Audio Interview: A Look at the U.S. Government's Covid-19 Strategy. N Engl J Med. 2022 07 21; 387(3):e11.
Audio Interview: A Look at the U.S. Government's Covid-19 Strategy.
Loesche M, Karlson EW, Talabi O, Zhou G, Boutin N, Atchley R, Loevinsohn G, Chang JBP, Hasdianda MA, Okenla A, Sampson E, Schram H, Magsipoc K, Goodman K, Donahue L, MacGowan M, Novack LA, Jarolim P, Baden LR, Nilles EJ
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies. Emerg Infect Dis. 2022 09; 28(9):1859-1862.
Longitudinal SARS-CoV-2 Nucleocapsid Antibody Kinetics, Seroreversion, and Implications for Seroepidemiologic Studies.
Audio Interview: Protecting the Immunocompromised from Covid-19. N Engl J Med. 2022 06 09; 386(23):e71.
Audio Interview: Protecting the Immunocompromised from Covid-19.
Lin DY, Baden LR, El Sahly HM, Essink B, Neuzil KM, Corey L, Miller J
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial. JAMA Netw Open. 2022 06 01; 5(6):e2215984.
Durability of Protection Against Symptomatic COVID-19 Among Participants of the mRNA-1273 SARS-CoV-2 Vaccine Trial.
Rubin EJ, Baden LR, Moore PL, Morrissey S
Audio Interview: Dissecting the Host Response to SARS-CoV-2. N Engl J Med. 2022 06 02; 386(22):e69.
Audio Interview: Dissecting the Host Response to SARS-CoV-2.
Audio Interview: Designing the Next Covid-19 Vaccine. N Engl J Med. 2022 07 07; 387(1):e6.
Audio Interview: Designing the Next Covid-19 Vaccine.
Audio Interview: Vaccinating Young Children against Covid-19. N Engl J Med. 2022 06 23; 386(25):e77.
Audio Interview: Vaccinating Young Children against Covid-19.
Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies. N Engl J Med. 2022 06 16; 386(24):e75.
Audio Interview: Viral Evolution and the Future of Monoclonal Antibodies.
Rubin EJ, Baden LR, Marks P, Morrissey S
Audio Interview: Covid-19 Vaccines and the FDA. N Engl J Med. 2022 07 14; 387(2):e10.
Audio Interview: Covid-19 Vaccines and the FDA.
Dryden-Peterson S, Kim A, Kim AY, Caniglia EC, Lennes I, Patel R, Gainer L, Dutton L, Donahue E, Gandhi RT, Baden LR, Woolley AE
Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system. medRxiv. 2022 Jun 17.
Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system.
Follmann D, Janes HE, Buhule OD, Zhou H, Girard B, Marks K, Kotloff K, Desjardins M, Corey L, Neuzil KM, Miller JM, El Sahly HM, Baden LR
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial. Ann Intern Med. 2022 09; 175(9):1258-1265.
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial.
Sherman AC, Crombie JL, Cheng C, Desjardins M, Zhou G, Ometoruwa O, Rooks R, Senussi Y, McDonough M, Guerrero LI, Kupelian J, Doss-Gollin S, Smolen KK, van Haren SD, Armand P, Levy O, Walt DR, Baden LR, Issa NC
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies. Open Forum Infect Dis. 2022 Aug; 9(8):ofac417.
Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies.
Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A, McGhee N, Tomassini JE, Chen X, Chang Y, Sutherland A, Montefiori DC, Girard B, Edwards DK, Feng J, Zhou H, Baden LR, Miller JM, Das R
A Bivalent Omicron-Containing Booster Vaccine against Covid-19. N Engl J Med. 2022 10 06; 387(14):1279-1291.
A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
Chalkias S, Eder F, Essink B, Khetan S, Nestorova B, Feng J, Chen X, Chang Y, Zhou H, Montefiori D, Edwards DK, Girard B, Pajon R, Dutko FJ, Leav B, Walsh SR, Baden LR, Miller JM, Das R
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial. Nat Med. 2022 11; 28(11):2388-2397.
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.
Rubin EJ, Baden LR, Swaminathan S, Morrissey S
Audio Interview: Covid-19 and the WHO. N Engl J Med. 2022 09 01; 387(9):e24.
Audio Interview: Covid-19: Where Are We Heading? N Engl J Med. 2022 10 20; 387(16):e47.
Audio Interview: Covid-19: Where Are We Heading?
Rubin EJ, Baden LR, Nkengasong JN, Morrissey S
Audio Interview: Infectious Disease in Africa. N Engl J Med. 2022 10 06; 387(14):e42.
Audio Interview: Infectious Disease in Africa.
Rubin EJ, Baden LR, Currier JS, Morrissey S
Audio Interview: Reinventing the Research Infrastructure to Address Covid-19. N Engl J Med. 2022 07 28; 387(4):e13.
Audio Interview: Reinventing the Research Infrastructure to Address Covid-19.
Rubin EJ, Baden LR, Neuzil KM, Morrissey S
Audio Interview: Developing New Covid-19 Vaccines. N Engl J Med. 2022 10 13; 387(15):e44.
Audio Interview: Developing New Covid-19 Vaccines.
Audio Interview: Combating Covid-19 Today and Tomorrow. N Engl J Med. 2022 08 11; 387(6):e17.
Audio Interview: Combating Covid-19 Today and Tomorrow.
Audio Interview: Choosing an Antiviral to Treat Covid-19. N Engl J Med. 2022 08 25; 387(8):e22.
Audio Interview: Choosing an Antiviral to Treat Covid-19.
Weiss ZF, DiCarlo JE, Basta DW, Kent S, Liakos A, Baden L, Brigl M, Kanjilal S, Cañete-Gibas C, Wiederhold NP, Basu SS
Annals of clinical microbiology and antimicrobials
Hidden in plain sight: urinary Cryptococcus neoformans missed by routine diagnostics in a patient with acute leukemia. Ann Clin Microbiol Antimicrob. 2022 Nov 12; 21(1):49.
Hidden in plain sight: urinary Cryptococcus neoformans missed by routine diagnostics in a patient with acute leukemia.
Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection. N Engl J Med. 2022 10 27; 387(17):e50.
Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox. N Engl J Med. 2022 08 04; 387(5):e16.
Audio Interview: Updated Covid-19 Vaccines and a Look at Monkeypox.
Audio Interview: Rolling Out New Covid-19 Vaccines. N Engl J Med. 2022 09 08; 387(10):e26.
Audio Interview: Rolling Out New Covid-19 Vaccines.
Stieh DJ, Barouch DH, Comeaux C, Sarnecki M, Stephenson KE, Walsh SR, Sawant S, Heptinstall J, Tomaras GD, Kublin JG, McElrath MJ, Cohen KW, De Rosa SC, Alter G, Ferrari G, Montefiori D, Mann P, Nijs S, Callewaert K, Goepfert PA, Edupuganti S, Karita E, Seaman MS, Corey L, Baden LR, Pau MG, Schuitemaker H, Tomaka F
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study. J Infect Dis. 2023 04 18; 227(8):939-950.
Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study.
Audio Interview: Developing Mucosal Immunity to Covid-19. N Engl J Med. 2022 09 15; 387(11):e29.
Audio Interview: Developing Mucosal Immunity to Covid-19.
Siangphoe U, Baden LR, El Sahly HM, Essink B, Ali K, Berman G, Tomassini JE, Deng W, Pajon R, McPhee R, Dixit A, Das R, Miller JM, Zhou H
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials. Clin Infect Dis. 2023 01 13; 76(2):271-280.
Associations of Immunogenicity and Reactogenicity After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine in the COVE and TeenCOVE Trials.
Ozonoff A, Schaenman J, Jayavelu ND, Milliren CE, Calfee CS, Cairns CB, Kraft M, Baden LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau KC, Davis MM, Hough CL, Messer WB, Higuita NIA, Metcalf JP, Atkinson MA, Brakenridge SC, Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study. EBioMedicine. 2022 Sep; 83:104208.
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study.
Audio Interview: Assessing Bivalent Vaccines against Covid-19. N Engl J Med. 2022 09 29; 387(13):e37.
Audio Interview: Assessing Bivalent Vaccines against Covid-19.
Rubin EJ, Baden LR, Daskalakis DC, Morrissey S
Audio Interview: Responding to Monkeypox. N Engl J Med. 2022 08 18; 387(7):e21.
Audio Interview: Responding to Monkeypox.
Bhimraj A, Morgan RL, Shumaker AH, Baden LR, Cheng VC, Edwards KM, Gallagher JC, Gandhi RT, Muller WJ, Nakamura MM, O'Horo JC, Shafer RW, Shoham S, Murad MH, Mustafa RA, Sultan S, Falck-Ytter Y
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022). Clin Infect Dis. 2024 06 27; 78(7):e250-e349.
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022).
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5. Arthritis Rheumatol. 2023 01; 75(1):E1-E16.
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5.
Audio Interview: Masking and Covid-19. N Engl J Med. 2022 11 10; 387(19):e56.
Audio Interview: Can Vaccines Prevent Transmission of Covid-19? N Engl J Med. 2022 09 22; 387(12):e30.
Audio Interview: Can Vaccines Prevent Transmission of Covid-19?
Rubin EJ, Baden LR, Hardin CC, Morrissey S
Audio Interview: Caring for Hospitalized Patients with Covid-19. N Engl J Med. 2022 11 03; 387(18):e51.
Audio Interview: The FDA and Covid-19 Vaccines. N Engl J Med. 2022 11 17; 387(20):e60.
Audio Interview: The FDA and Covid-19 Vaccines.
Audio Interview: Making Choices about Covid-19. N Engl J Med. 2022 11 24; 387(21):e64.
Audio Interview: Making Choices about Covid-19.
Dryden-Peterson S, Kim A, Joyce MR, Johnson JA, Kim AY, Baden LR, Woolley AE
Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System. Open Forum Infect Dis. 2022 Nov; 9(11):ofac565.
Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System.
Audio Interview: Five Disease Outbreaks beyond Covid-19. N Engl J Med. 2022 12 01; 387(22):e68.
Audio Interview: Five Disease Outbreaks beyond Covid-19.
Rubin EJ, Baden LR, Hlatshwayo Davis M, Morrissey S
Audio Interview: Covid-19 and Health Equity. N Engl J Med. 2022 12 08; 387(23):e73.
Audio Interview: Covid-19 and Health Equity.
Bass AR, Chakravarty E, Akl EA, Bingham CO, Calabrese L, Cappelli LC, Johnson SR, Imundo LF, Winthrop KL, Arasaratnam RJ, Baden LR, Berard R, Bridges SL, Cheah JTL, Curtis JR, Ferguson PJ, Hakkarinen I, Onel KB, Schultz G, Sivaraman V, Smith BJ, Sparks JA, Vogel TP, Williams EA, Calabrese C, Cunha JS, Fontanarosa J, Gillispie-Taylor MC, Gkrouzman E, Iyer P, Lakin KS, Legge A, Lo MS, Lockwood MM, Sadun RE, Singh N, Sullivan N, Tam H, Turgunbaev M, Turner AS, Reston J
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023 03; 75(3):449-464.
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases.
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Rheumatol. 2023 03; 75(3):333-348.
Brook B, Fatou B, Kumar Checkervarty A, Barman S, Sweitzer C, Bosco AN, Sherman AC, Baden LR, Morrocchi E, Sanchez-Schmitz G, Palma P, Nanishi E, O'Meara TR, McGrath ME, Frieman MB, Soni D, van Haren SD, Ozonoff A, Diray-Arce J, Steen H, Dowling DJ, Levy O
The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo. Res Sq. 2022 Dec 21.
The mRNA vaccine BNT162b2 demonstrates impaired TH1 immunogenicity in human elders in vitro and aged mice in vivo.
Audio Interview: Applying New Studies of Mpox and Ebola to Covid-19. N Engl J Med. 2022 12 15; 387(24):e74.
Audio Interview: Applying New Studies of Mpox and Ebola to Covid-19.
Hahn G, Lee S, Prokopenko D, Abraham J, Novak T, Hecker J, Cho M, Khurana S, Baden LR, Randolph AG, Weiss ST, Lange C
Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest. BMC Bioinformatics. 2022 Dec 19; 23(1):547.
Unsupervised outlier detection applied to SARS-CoV-2 nucleotide sequences can identify sequences of common variants and other variants of interest.
Audio Interview: Potential Covid Vaccine Strategies. N Engl J Med. 2022 12 22; 387(25):e75.
Audio Interview: Potential Covid Vaccine Strategies.
Woolley AE, Gandhi AR, Jones ML, Kim JJ, Mallidi HR, Givertz MM, Baden LR, Mehra MR, Neilan AAM
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients. Transplantation. 2023 04 01; 107(4):961-969.
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients.
Audio Interview: The Expanding Arsenal of Oral Agents to Treat Covid-19. N Engl J Med. 2023 01 05; 388(1):e7.
Audio Interview: The Expanding Arsenal of Oral Agents to Treat Covid-19.
Dryden-Peterson S, Kim A, Kim AY, Caniglia EC, Lennes IT, Patel R, Gainer L, Dutton L, Donahue E, Gandhi RT, Baden LR, Woolley AE
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study. Ann Intern Med. 2023 01; 176(1):77-84.
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study.
Audio Interview: Covid-19 Vaccines and New Viral Variants. N Engl J Med. 2023 01 12; 388(2):e8.
Audio Interview: Covid-19 Vaccines and New Viral Variants.
Audio Interview: Weighing the Protective Value of Covid-19 Infection. N Engl J Med. 2023 01 19; 388(3):e13.
Audio Interview: Weighing the Protective Value of Covid-19 Infection.
Mena Lora AJ, Long JE, Huang Y, Baden LR, El Sahly HM, Follmann D, Goepfert P, Gray G, Grinsztejn B, Kotloff K, Rouphael N, Sobieszczyk M, Walsh SR, Andriesen J, Shah KA, Zhang Y, Gilbert P, Janes H, Gay CL, Falsey AR, Tripp RL, Gorman RL, Tong T, Marovich M, Neuzil K, Corey L, Kublin JG
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials. JAMA Netw Open. 2023 01 03; 6(1):e2251974.
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
Sherman AC, Cheng CA, Swank Z, Zhou G, Li X, Issa NC, Walt DR, Baden LR, Soiffer RJ
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation. Transplant Cell Ther. 2023 05; 29(5):337.e1-337.e5.
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell Transplantation.
Baden L, Catteruccia F, Diabaté A, Donini C, Nosten F, O'Neill S, Osier F, Phyo AP, White N
Malaria - Epidemiology, Treatment, and Prevention. N Engl J Med. 2023 02 02; 388(5):e9.
Malaria - Epidemiology, Treatment, and Prevention.
Audio Interview: Updating and Standardizing Covid-19 Vaccines. N Engl J Med. 2023 02 02; 388(5):e21.
Audio Interview: Updating and Standardizing Covid-19 Vaccines.
Nanishi E, Borriello F, Seo HS, O'Meara TR, McGrath ME, Saito Y, Chen J, Diray-Arce J, Song K, Xu AZ, Barman S, Menon M, Dong D, Caradonna TM, Feldman J, Hauser BM, Schmidt AG, Baden LR, Ernst RK, Dillen C, Yu J, Chang A, Hilgers L, Platenburg PP, Dhe-Paganon S, Barouch DH, Ozonoff A, Zanoni I, Frieman MB, Dowling DJ, Levy O
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. NPJ Vaccines. 2023 Feb 14; 8(1):18.
Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
Rubin EJ, Baden LR, Graham BS, Morrissey S
Audio Interview: What to Expect from Covid-19 Vaccines. N Engl J Med. 2023 02 16; 388(7):e23.
Audio Interview: What to Expect from Covid-19 Vaccines.
Cohen KW, Fiore-Gartland A, Walsh SR, Yusim K, Frahm N, Elizaga ML, Maenza J, Scott H, Mayer KH, Goepfert PA, Edupuganti S, Pantaleo G, Hutter J, Morris DE, De Rosa SC, Geraghty DE, Robb ML, Michael NL, Fischer W, Giorgi EE, Malhi H, Pensiero MN, Ferrari G, Tomaras GD, Montefiori DC, Gilbert PB, McElrath MJ, Haynes BF, Korber BT, Baden LR
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults. J Clin Invest. 2023 02 15; 133(4).
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults.
Bloch EM, Focosi D, Shoham S, Senefeld J, Tobian AAR, Baden LR, Tiberghien P, Sullivan DJ, Cohn C, Dioverti V, Henderson JP, So-Osman C, Juskewitch JE, Razonable RR, Franchini M, Goel R, Grossman BJ, Casadevall A, Joyner MJ, Avery RK, Pirofski LA, Gebo KA
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019. Clin Infect Dis. 2023 06 08; 76(11):2018-2024.
Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice. NPJ Vaccines. 2023 Mar 03; 8(1):30.
Publisher Correction: Carbohydrate fatty acid monosulphate: oil-in-water adjuvant enhances SARS-CoV-2 RBD nanoparticle-induced immunogenicity and protection in mice.
Audio Interview: The Path Forward for Covid-19 Therapeutics. N Engl J Med. 2023 03 02; 388(9):e36.
Audio Interview: The Path Forward for Covid-19 Therapeutics.
Aleissa MM, Little JS, Davey S, Saucier A, Zhou G, Gonzalez-Bocco IH, Crombie JL, Looka A, Baden LR, Issa NC, Hammond SP, Jacobson CA, Sherman AC
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients. Transplant Cell Ther. 2023 06; 29(6):398.e1-398.e5.
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients.
Audio Interview: The Future of Covid-19 Research. N Engl J Med. 2023 03 16; 388(11):e39.
Audio Interview: The Future of Covid-19 Research.
Follmann D, Janes HE, Chu E, Jayashankar L, Petropoulos CJ, Serebryannyy L, Carroll R, Jean-Baptiste N, Narpala S, Lin BC, McDermott A, Novak RM, Graciaa DS, Rolsma S, Magaret CA, Doria-Rose N, Corey L, Neuzil KM, Pajon R, Miller JM, Donis RO, Koup RA, Baden LR, El Sahly HM
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial. Open Forum Infect Dis. 2023 Mar; 10(3):ofad069.
Kinetics of the Antibody Response to Symptomatic SARS-CoV-2 Infection in Vaccinated and Unvaccinated Individuals in the Blinded Phase of the mRNA-1273 COVID-19 Vaccine Efficacy Trial.
Tolan NV, DeSimone MS, Fernandes MD, Lewis JE, Simmons DP, Schur PH, Brigl M, Tanasijevic MJ, Desjardins M, Sherman AC, Baden LR, Snyder M, Melanson SE
Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility. Clin Biochem. 2023 Jul; 117:60-68.
Lessons learned: A look back at the performance of nine COVID-19 serologic assays and their proposed utility.
Strategic Masking to Protect Patients from All Respiratory Viral Infections. N Engl J Med. 2023 07 06; 389(1):4-6.
Strategic Masking to Protect Patients from All Respiratory Viral Infections.
Desjardins M, Cunningham P, Mitre X, Pierre D, Montesano C, Woods T, Oganezova K, Krauss JH, Von SS, Kupelian JA, Li X, Gothing JA, Kleinjan JA, Zhou G, Piantadosi S, Sherman AC, Walsh SR, Issa NC, Kaufman RM, Baden LR
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors. Blood. 2023 07 13; 142(2):202-209.
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors.
El Zarif T, Nassar AH, Adib E, Fitzgerald BG, Huang J, Mouhieddine TH, Rubinstein PG, Nonato T, McKay RR, Li M, Mittra A, Owen DH, Baiocchi RA, Lorentsen M, Dittus C, Dizman N, Falohun A, Abdel-Wahab N, Diab A, Bankapur A, Reed A, Kim C, Arora A, Shah NJ, El-Am E, Kozaily E, Abdallah W, Al-Hader A, Abu Ghazal B, Saeed A, Drolen C, Lechner MG, Drakaki A, Baena J, Nebhan CA, Haykal T, Morse MA, Cortellini A, Pinato DJ, Dalla Pria A, Hall E, Bakalov V, Bahary N, Rajkumar A, Mangla A, Shah V, Singh P, Aboubakar Nana F, Lopetegui-Lia N, Dima D, Dobbs RW, Funchain P, Saleem R, Woodford R, Long GV, Menzies AM, Genova C, Barletta G, Puri S, Florou V, Idossa D, Saponara M, Queirolo P, Lamberti G, Addeo A, Bersanelli M, Freeman D, Xie W, Reid EG, Chiao EY, Sharon E, Johnson DB, Ramaswami R, Bower M, Emu B, Marron TU, Choueiri TK, Baden LR, Lurain K, Sonpavde GP, Naqash AR
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. J Clin Oncol. 2023 07 20; 41(21):3712-3723.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, Bäcker M, Novak RM, Walter EB, Jackson LA, Little SJ, Immergluck LC, Mahgoub SM, Whitaker JA, Babu TM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Sonja C, Montefiori DC, Roberts PC, Beigel JH
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. medRxiv. 2023 Mar 31.
Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, Bäcker M, Novak RM, Walter EB, Jackson LA, Little SJ, Immergluck LC, Mahgoub SM, Whitaker JA, Babu TM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial. Clin Infect Dis. 2023 08 22; 77(4):560-564.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Audio Interview: Ending the Covid-19 Emergency. N Engl J Med. 2023 05 11; 388(19):e72.
Audio Interview: Ending the Covid-19 Emergency.
Harris CE, Vijenthira A, Ong SY, Baden LR, Hicks LK, Baird JH
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies. Am Soc Clin Oncol Educ Book. 2023 May; 43:e390778.
COVID-19 and Other Viral Infections in Patients With Hematologic Malignancies.
End of a Declared Public Health Emergency - Implications for U.S. Emergency Use Authorizations. N Engl J Med. 2023 03 30; 388(13):1153-1155.
End of a Declared Public Health Emergency - Implications for U.S. Emergency Use Authorizations.
Branche A, Rouphael N, Diemert D, Falsey A, Losada C, Baden LR, Frey S, Whitaker J, Little S, Anderson E, Walter E, Novak R, Rupp R, Jackson L, Babu T, Kottkamp A, Luetkemeyer A, Immergluck L, Presti R, Backer M, Winokur P, Mahgoub S, Goepfert P, Fusco D, Malkin E, Bethony J, Walsh E, Graciaa D, Samaha H, Sherman A, Walsh S, Abate G, Oikonomopoulou Z, El Sahly H, Martin T, Kamidani S, Smith M, Ladner B, Porterfield L, Dunstan M, Wald A, Davis T, Atmar R, Mulligan M, Lyke K, Posavad C, Meagher M, Stephens D, Neuzil K, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis T, Giebeig L, Eaton A, Netzl A, Wilks S, Tureli S, Makhene M, Crandon S, Montefiori D, Makowski M, Smith D, Nayak S, Roberts P, Beigel J
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial. Res Sq. 2023 May 05.
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial.
Theodore DA, Branche AR, Zhang L, Graciaa DS, Choudhary M, Hatlen TJ, Osman R, Babu TM, Robinson ST, Gilbert PB, Follmann D, Janes H, Kublin JG, Baden LR, Goepfert P, Gray GE, Grinsztejn B, Kotloff KL, Gay CL, Leav B, Miller J, Hirsch I, Sadoff J, Dunkle LM, Neuzil KM, Corey L, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. 2023 07 03; 6(7):e2323349.
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Follmann D, O'Brien MP, Fintzi J, Fay MP, Montefiori D, Mateja A, Herman GA, Hooper AT, Turner KC, Chan KC, Forleo-Neto E, Isa F, Baden LR, El Sahly HM, Janes H, Doria-Rose N, Miller J, Zhou H, Dang W, Benkeser D, Fong Y, Gilbert PB, Marovich M, Cohen MS
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration. Nat Commun. 2023 06 17; 14(1):3605.
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. medRxiv. 2023 Jun 10.
Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Audio Interview: The Lasting Effects of Covid-19. N Engl J Med. 2023 05 25; 388(21):e76.
Audio Interview: The Lasting Effects of Covid-19.
Audio Interview: When to Get a Second Covid-19 Booster Shot. N Engl J Med. 2023 04 13; 388(15):e64.
Audio Interview: When to Get a Second Covid-19 Booster Shot.
Yue H, Nowak RP, Overwijn D, Payne NC, Fischinger S, Atyeo C, Lam EC, St Denis K, Brais LK, Konishi Y, Sklavenitis-Pistofidis R, Baden LR, Nilles EJ, Karlson EW, Yu XG, Li JZ, Woolley AE, Ghobrial IM, Meyerhardt JA, Balazs AB, Alter G, Mazitschek R, Fischer ES
Diagnostic TR-FRET assays for detection of antibodies in patient samples. Cell Rep Methods. 2023 03 27; 3(3):100421.
Diagnostic TR-FRET assays for detection of antibodies in patient samples.
Turley CB, Tables L, Fuller T, Sanders LJ, Scott H, Moodley A, Woodward Davis A, Leav B, Miller J, Schoemaker K, Vandebosch A, Sadoff J, Woo W, Cho I, Dunkle LM, Li S, van der Laan L, Gilbert PB, Follmann D, Jaynes H, Kublin JG, Baden LR, Goepfert P, Kotloff K, Gay CL, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Rouphael N, Luedtke A
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials. Vaccine. 2023 07 25; 41(33):4899-4906.
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.
Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Williamson BD, Garver J, Altonen E, Rudge T, Huynh C, Miller J, El Sahly HM, Baden LR, Frey S, Malkin E, Spector SA, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA, Gilbert PB
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial. Sci Transl Med. 2023 04 19; 15(692):eade9078.
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
Audio Interview: Ending the Covid-19 Public Health Emergency. N Engl J Med. 2023 03 30; 388(13):e53.
Audio Interview: Ending the Covid-19 Public Health Emergency.
Rubin EJ, Baden LR, Abdool Karim Q, Abdool Karim SS, Wenzel RP, Morrissey S
Audio Interview: Preparing for the Next Pandemic. N Engl J Med. 2023 04 27; 388(17):e66.
Audio Interview: Preparing for the Next Pandemic.
Narayanasamy S, Curtis LH, Hernandez AF, Woods CW, Moody MA, Sulkowski M, Turbett SE, Baden LR, Gulick RM, Pau AK, Adam SJ, Marks P, Stockbridge NL, Dobbins JR, Krofah E, Leav B, Pang P, Roessig L, Vedin O, Waldstreicher J, Berman SC, Cremisi H, Schofield L, Gandhi RT, Naggie S
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank. Clin Infect Dis. 2023 12 15; 77(12):1635-1643.
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
Audio Interview: Dr. Fauci on Infectious Disease Challenges. N Engl J Med. 2023 Jun 15; 388(24):e82.
Audio Interview: Dr. Fauci on Infectious Disease Challenges.
Chalkias S, Harper C, Vrbicky K, Walsh SR, Essink B, Brosz A, McGhee N, Tomassini JE, Chen X, Sutherland A, Montefiori DC, Girard B, Edwards DK, Zhou H, Baden LR, Miller JM, Das R
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19. Nat Commun. 2023 08 23; 14(1):5125.
Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19.
Chalkias S, Whatley JL, Eder F, Essink B, Khetan S, Bradley P, Brosz A, McGhee N, Tomassini JE, Chen X, Zhao X, Sutherland A, Shen X, Girard B, Edwards DK, Feng J, Zhou H, Walsh S, Montefiori DC, Baden LR, Miller JM, Das R
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results. Nat Med. 2023 09; 29(9):2325-2333.
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results.
Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, McQuarrie LJ, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Kokogho A, Crowell TA, Aleissa M, Lupan AM, Davey S, Park Chang JB, Baden LR, Walsh SR, Sherman AC
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients. Open Forum Infect Dis. 2023 Jul; 10(7):ofad349.
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant Recipients.
Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nat Med. 2023 09; 29(9):2334-2346.
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Rick AM, Laurens MB, Huang Y, Yu C, Martin TCS, Rodriguez CA, Rostad CA, Maboa RM, Baden LR, El Sahly HM, Grinsztejn B, Gray GE, Gay CL, Gilbert PB, Janes HE, Kublin JG, Huang Y, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Goepfert PA, Walsh SR, Follmann D, Kotloff KL
Risk of COVID-19 after natural infection or vaccination. EBioMedicine. 2023 Oct; 96:104799.
Risk of COVID-19 after natural infection or vaccination.
Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, Keefer M, Edupuganti S, Rodriguez B, Frank I, Scott H, Stranix-Chibanda L, Gurunathan S, Koutsoukos M, Van Der Meeren O, DiazGranados CA, Paez C, Andersen-Nissen E, Kublin J, Corey L, Ferrari G, Tomaras G, McElrath MJ
Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120. J Infect Dis. 2024 Aug 16; 230(2):e405-e415.
Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.
Hejazi NS, Shen X, Carpp LN, Benkeser D, Follmann D, Janes HE, Baden LR, El Sahly HM, Deng W, Zhou H, Leav B, Montefiori DC, Gilbert PB
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial. Int J Infect Dis. 2023 Dec; 137:28-39.
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial.
Huang Y, Hejazi NS, Blette B, Carpp LN, Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Kenny A, Carone M, Huynh C, Miller J, El Sahly HM, Baden LR, Jackson LA, Campbell TB, Clark J, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Pajon R, Follmann D, Donis RO, Koup RA, Gilbert PB
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial. Viruses. 2023 09 29; 15(10).
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial.
Ozonoff A, Schaenman J, Jayavelu ND, Milliren CE, Calfee CS, Cairns CB, Kraft M, Baden LR, Shaw AC, Krammer F, van Bakel H, Esserman DA, Liu S, Sesma AF, Simon V, Hafler DA, Montgomery RR, Kleinstein SH, Levy O, Bime C, Haddad EK, Erle DJ, Pulendran B, Nadeau KC, Davis MM, Hough CL, Messer WB, Agudelo Higuita NI, Metcalf JP, Atkinson MA, Brakenridge SC, Corry D, Kheradmand F, Ehrlich LIR, Melamed E, McComsey GA, Sekaly R, Diray-Arce J, Peters B, Augustine AD, Reed EF, Altman MC, Becker PM, Rouphael N
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]. EBioMedicine. 2023 Dec; 98:104860.
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208].
Little JS, Duléry R, Shapiro RM, Aleissa MM, Prockop SE, Koreth J, Ritz J, Antin JH, Cutler C, Nikiforow S, Romee R, Issa NC, Ho VT, Baden LR, Soiffer RJ, Gooptu M
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft. Transplant Cell Ther. 2024 02; 30(2):233.e1-233.e14.
Opportunistic Infections in Patients Receiving Post-Transplantation Cyclophosphamide: Impact of Haploidentical versus Unrelated Donor Allograft.
Pries-Heje MM, Bundgaard H, Iversen KK, Baden LR, Woolley AE
Infective Endocarditis Antibiotic Prophylaxis: Review of the Evidence and Guidelines. Curr Cardiol Rep. 2023 12; 25(12):1873-1881.
Infective Endocarditis Antibiotic Prophylaxis: Review of the Evidence and Guidelines.
Ozonoff A, Jayavelu ND, Liu S, Melamed E, Milliren CE, Qi J, Geng LN, McComsey GA, Cairns CB, Baden LR, Schaenman J, Shaw AC, Samaha H, Seyfert-Margolis V, Krammer F, Rosen LB, Steen H, Syphurs C, Dandekar R, Shannon CP, Sekaly RP, Ehrlich LIR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Sesma AF, Simon V, van Bakel H, Kim-Schulze S, Hafler DA, Levy O, Kraft M, Bime C, Haddad EK, Calfee CS, Erle DJ, Langelier CR, Eckalbar W, Bosinger SE, Peters B, Kleinstein SH, Reed EF, Augustine AD, Diray-Arce J, Maecker HT, Altman MC, Montgomery RR, Becker PM, Rouphael N
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study. Nat Commun. 2024 01 03; 15(1):216.
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study.
Langelier C, Pickering H, Schaenman J, Phan H, Maguire C, Tsitsiklis A, Rouphael N, Higuita N, Atkinson M, Breckenridge S, Fung M, Messer W, Salehi-Rad R, Altman M, Becker P, Bosinger S, Eckalbar W, Hoch A, Jayavelu N, Kim-Schulze S, Jenkins M, Kleinstein S, Krammer F, Maecker H, Ozonoff A, Diray-Arce J, Shaw A, Baden L, Levy O, Reed E
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant Recipients. Res Sq. 2023 Dec 20.
Host-Microbe Multi-omic Profiling Identifies a Unique Program of COVID-19 Inflammatory Dysregulation in Solid Organ Transplant Recipients.
Little JS, Oakley MS, Thorner AR, Johnston D, Majam V, Liakos AD, Novack LA, Zheng H, Meredith S, Chou CK, Newton BR, Soiffer RJ, Krause PJ, Baden LR, Kumar S
Immune Control in Repeated Babesia microti Infection in a Patient With B-Cell Deficiency. Open Forum Infect Dis. 2024 Jan; 11(1):ofad568.
Immune Control in Repeated Babesia microti Infection in a Patient With B-Cell Deficiency.
Walsh SR, Gay CL, Karuna ST, Hyrien O, Skalland T, Mayer KH, Sobieszczyk ME, Baden LR, Goepfert PA, Del Rio C, Pantaleo G, Andrew P, Karg C, He Z, Lu H, Paez CA, Baumblatt JAG, Polakowski LL, Chege W, Janto S, Han X, Huang Y, Dumond J, Ackerman ME, McDermott AB, Flach B, Piwowar-Manning E, Seaton K, Tomaras GD, Montefiori DC, Gama L, Mascola JR
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087). medRxiv. 2024 Jan 11.
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087).
Miner MD, deCamp A, Grunenberg N, De Rosa SC, Fiore-Gartland A, Bar K, Spearman P, Allen M, Yu PC, Manso B, Frahm N, Kalams S, Baden L, Keefer MC, Scott HM, Novak R, Van Tieu H, Tomaras GD, Kublin JG, McElrath MJ, Corey L, Frank I
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial. EBioMedicine. 2024 Feb; 100:104987.
Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.
Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2024 Feb 05; 15(1):1075.
Little JS, Coughlin C, Hsieh C, Lanza M, Huang WY, Kumar A, Dandawate T, Tucker R, Gable P, Vazquez Deida AA, Moulton-Meissner H, Stevens V, McAllister G, Ewing T, Diaz M, Glowicz J, Winkler ML, Pecora N, Kubiak DW, Pearson JC, Luskin MR, Sherman AC, Woolley AE, Brandeburg C, Bolstorff B, McHale E, Fortes E, Doucette M, Smole S, Bunnell C, Gross A, Platt D, Desai S, Fiumara K, Issa NC, Baden LR, Rhee C, Klompas M, Baker MA
Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia. Open Forum Infect Dis. 2024 Mar; 11(3):ofae048.
Neuroinvasive Bacillus cereus Infection in Immunocompromised Hosts: Epidemiologic Investigation of 5 Patients With Acute Myeloid Leukemia.
Chalkias S, McGhee N, Whatley JL, Essink B, Brosz A, Tomassini JE, Girard B, Edwards DK, Wu K, Nasir A, Lee D, Avena LE, Feng J, Deng W, Montefiori DC, Baden LR, Miller JM, Das R
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines. J Infect Dis. 2024 Aug 16; 230(2):e279-e286.
Interim Report of the Reactogenicity and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 XBB-Containing Vaccines.
Sherman AC, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, Kublin JG, Goepfert PA, Kotloff K, Rouphael N, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Nason M, Baden LR, Gay CL
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials. Clin Infect Dis. 2024 08 16; 79(2):364-374.
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.
Erdmann N, Williams WB, Walsh SR, Cain DW, Clark M, Tuck R, Holmes S, Clardy B, Foulger A, Parks R, Barr M, Eaton A, Saunders KO, Grunenberg N, Edlefsen P, Goepfert PA, Cohen KW, Maenza J, Mayer K, Van Tieu H, Sobieszczyk ME, Swann E, Lu H, De Rosa SC, Sagawa ZK, Lin BC, Carrol RE, McKee K, Doria-Rose NA, Louder MK, Moody MA, Fox CB, Ferrari G, Edwards RJ, Acharya P, Alam SM, Tomaras GD, Montefiori DC, Gilbert PB, McElrath MJ, Corey L, Haynes BF, Baden LR
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals. medRxiv. 2025 Aug 22.
An HIV-1 gp41 peptide-liposome vaccine elicits neutralizing epitope-targeted antibody responses in healthy individuals.
Williams WB, Alam SM, Ofek G, Erdmann N, Montefiori DC, Seaman MS, Wagh K, Korber B, Edwards RJ, Mansouri K, Eaton A, Cain DW, Martin M, Hwang J, Arus-Altuz A, Lu X, Cai F, Jamieson N, Parks R, Barr M, Foulger A, Anasti K, Patel P, Sammour S, Parsons RJ, Huang X, Lindenberger J, Fetics S, Janowska K, Niyongabo A, Janus BM, Astavans A, Fox CB, Mohanty I, Evangelous T, Chen Y, Berry M, Kirshner H, Van Itallie E, Saunders KO, Wiehe K, Cohen KW, McElrath MJ, Corey L, Acharya P, Walsh SR, Baden LR, Haynes BF
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans. Cell. 2024 Jun 06; 187(12):2919-2934.e20.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
How To Measure Benefit in a Changing Pandemic - Olgotrelvir for SARS-CoV-2. NEJM Evid. 2024 Jun; 3(6):EVIDe2400144.
How To Measure Benefit in a Changing Pandemic - Olgotrelvir for SARS-CoV-2.
Harvard Clinical and Translational Science Center
Rubin EJ, Baden LR, Daskalakis D, Marston H, Morrissey S
Audio Interview: Preparing for a Possible Avian Influenza Outbreak. N Engl J Med. 2024 06 06; 390(21):e55.
Audio Interview: Preparing for a Possible Avian Influenza Outbreak.
Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA Netw Open. 2024 05 01; 7(5):e2412835.
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Hahn WO, Parks KR, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Woodward Davis AS, Duplessis C, Tomai M, Dey AK, Sagawa ZK, De Rosa SC, Seese A, Siddaramaiah LK, Stamatatos L, Lee WH, Sewall LM, Karlinsey D, Turner HL, Rubin V, Furth S, MacPhee K, Duff M, Corey L, Keefer MC, Edupuganti S, Frank I, Maenza J, Baden LR, Hyrien O, Sanders RW, Moore JP, Ward AB, Tomaras GD, Montefiori DC, Rouphael N, McElrath MJ
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies. medRxiv. 2024 May 09.
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies.
Rubin EJ, Baden LR, Marrazzo J, Monto A, Morrissey S
Audio Interview: The Current State of Avian Influenza. N Engl J Med. 2024 06 06; 390(21):e54.
Audio Interview: The Current State of Avian Influenza.
Sherman AC, van Haren SD, Borberg E, Swank Z, Aleissa M, Tong A, Rooks R, Kanwal U, Levine H, Yates B, Izaguirre N, Ryff K, Thomas S, Parisi L, Li X, Walt DR, Levy O, Walsh SR, Issa NC, Baden LR
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series. Vaccine. 2024 09 17; 42(22):126054.
Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series.
Schüller SS, Barman S, Mendez-Giraldez R, Soni D, Daley J, Baden LR, Levy O, Dowling DJ
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro. Commun Biol. 2024 06 08; 7(1):709.
Immune profiling of age and adjuvant-specific activation of human blood mononuclear cells in vitro.
Walsh SR, Gay CL, Karuna ST, Hyrien O, Skalland T, Mayer KH, Sobieszczyk ME, Baden LR, Goepfert PA, Del Rio C, Pantaleo G, Andrew P, Karg C, He Z, Lu H, Paez CA, Baumblatt JAG, Polakowski LL, Chege W, Anderson MA, Janto S, Han X, Huang Y, Dumond J, Ackerman ME, McDermott AB, Flach B, Piwowar-Manning E, Seaton K, Tomaras GD, Montefiori DC, Gama L, Mascola JR
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial. PLoS Med. 2024 Jun; 21(6):e1004329.
Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial.
Harris CE, Vaidya V, Lan Z, Klompas M, Rhee C, Baden LR, Baker MA
SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions. Open Forum Infect Dis. 2024 Jul; 11(7):ofae367.
SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions.
The Real PURPOSE of PrEP - Effectiveness, Not Efficacy. N Engl J Med. 2024 Oct 03; 391(13):1246-1247.
The Real PURPOSE of PrEP - Effectiveness, Not Efficacy.
Brook B, Duval V, Barman S, Speciner L, Sweitzer C, Khanmohammed A, Menon M, Foster K, Ghosh P, Abedi K, Koster J, Nanishi E, Baden LR, Levy O, VanCott T, Micol R, Dowling DJ
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70. Sci Transl Med. 2024 07 24; 16(757):eadm8451.
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70.
Lezo Ramirez D, Koleske E, Ometoruwa O, Park Chang JB, Kanwal U, Morreale N, Avila Paz AA, Tong A, Baden LR, Sherman AC, Walsh SR
Evaluating enrollment and representation in COVID-19 and HIV vaccine clinical trials. Front Public Health. 2024; 12:1411970.
Evaluating enrollment and representation in COVID-19 and HIV vaccine clinical trials.
Janes H, Fisher LH, Kee JJ, Parameswaran L, Goepfert PA, Falsey AR, Ludwig J, Magaret CA, Gilbert PB, Kublin JG, Rouphael N, Sobieszczyk ME, El Sahly HM, Baden LR, Grinsztejn B, Walsh SR, Gray GE, Kotloff KL, Gay CL, Greninger AL, Tapia MD, Hammershaimb EA, Priddy FH, Green JA, Struyf F, Dunkle L, Neuzil KM, Corey L, Huang Y
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. J Infect Dis. 2024 Dec 16; 230(6):1384-1389.
Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
Hahn WO, Parks KR, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Woodward Davis AS, Duplessis C, Tomai M, Dey AK, Sagawa ZK, De Rosa SC, Seese A, Kallur Siddaramaiah L, Stamatatos L, Lee WH, Sewall LM, Karlinsey D, Turner HL, Rubin V, Furth S, MacPhee K, Duff M, Corey L, Keefer MC, Edupuganti S, Frank I, Maenza J, Baden LR, Hyrien O, Sanders RW, Moore JP, Ward AB, Tomaras GD, Montefiori DC, Rouphael N, McElrath MJ
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies. J Exp Med. 2024 Oct 07; 221(10).
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
Little JS, Hurtado RM, Boire N, Baden LR, Laga AC, Silk AW, Jacobson CA
Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma. Open Forum Infect Dis. 2024 Sep; 11(9):ofae460.
Disseminated Mycobacterium avium Complex Infection Following CD3/CD20 Bispecific Antibody Therapy in a Patient With Follicular Lymphoma.
Baden LR, El Sahly HM, Essink B, Follmann D, Hachigian G, Strout C, Overcash JS, Doblecki-Lewis S, Whitaker JA, Anderson EJ, Neuzil K, Corey L, Priddy F, Tomassini JE, Brown M, Girard B, Stolman D, Urdaneta V, Wang X, Deng W, Zhou H, Dixit A, Das R, Miller JM
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases. Nat Commun. 2024 Aug 29; 15(1):7469.
Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and booster phases.
Bhatt AS, Freeman SS, Herrera AF, Pedamallu CS, Gevers D, Duke F, Jung J, Michaud M, Walker BJ, Young S, Earl AM, Kostic AD, Ojesina AI, Hasserjian R, Ballen KK, Chen YB, Hobbs G, Antin JH, Soiffer RJ, Baden LR, Garrett WS, Hornick JL, Marty FM, Meyerson M
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013 Aug 08; 369(6):517-28.
Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.
Lyon GM, Abdul-Ali D, Loeffler J, White PL, Wickes B, Herrera ML, Alexander BD, Baden LR, Clancy C, Denning D, Nguyen MH, Sugrue M, Wheat LJ, Wingard JR, Donnelly JP, Barnes R, Patterson TF, Caliendo AM
Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis. J Clin Microbiol. 2013 Jul; 51(7):2403-5.
Development and evaluation of a calibrator material for nucleic acid-based assays for diagnosing aspergillosis.
Kalams SA, Parker SD, Elizaga M, Metch B, Edupuganti S, Hural J, De Rosa S, Carter DK, Rybczyk K, Frank I, Fuchs J, Koblin B, Kim DH, Joseph P, Keefer MC, Baden LR, Eldridge J, Boyer J, Sherwat A, Cardinali M, Allen M, Pensiero M, Butler C, Khan AS, Yan J, Sardesai NY, Kublin JG, Weiner DB
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis. 2013 Sep 01; 208(5):818-29.
Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
Fong Y, Dang L, Zhang B, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Follmann D, Gilbert PB
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 02 05; 80(1):223-227.
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial.
Zhang B, Fong Y, Fintzi J, Chu E, Janes HE, Kenny A, Carone M, Benkeser D, van der Laan LWP, Deng W, Zhou H, Wang X, Lu Y, Yu C, Borate B, Chen H, Reeder I, Carpp LN, Houchens CR, Martins K, Jayashankar L, Huynh C, Fichtenbaum CJ, Kalams S, Gay CL, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Priddy F, Das R, Girard B, El Sahly HM, Baden LR, Jones T, Donis RO, Koup RA, Gilbert PB, Follmann D
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial. Nat Commun. 2024 09 11; 15(1):7954.
Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial.
Bhimraj A, Falck-Ytter Y, Kim AY, Li JZ, Baden LR, Johnson S, Shafer RW, Shoham S, Tebas P, Bedimo R, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Martin GS, MacBrayne C, Nadig N, Nakamura MM, Shumaker AH, Tien P, Loveless J, Morgan RL, Gandhi RT
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i6-i12.
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis.
Rubin EJ, Baden LR, Nsanzimana S, Morrissey S
Audio Interview: The Marburg Virus Outbreak in Rwanda. N Engl J Med. 2024 Nov 07; 391(18):e49.
Audio Interview: The Marburg Virus Outbreak in Rwanda.
Brook B, Checkervarty AK, Barman S, Sweitzer C, Bosco AN, Sherman AC, Baden LR, Morrocchi E, Sanchez-Schmitz G, Palma P, Nanishi E, O'Meara TR, McGrath ME, Frieman MB, Soni D, van Haren SD, Ozonoff A, Diray-Arce J, Steen H, Dowling DJ, Levy O
The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo. iScience. 2024 Nov 15; 27(11):111055.
The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo.
Maguire C, Chen J, Rouphael N, Pickering H, Phan HV, Glascock A, Chu V, Dandekar R, Corry D, Kheradmand F, Baden LR, Selaky R, McComsey GA, Haddad EK, Cairns CB, Pulendran B, Fernandez-Sesma A, Simon V, Metcalf JP, Higuita NIA, Messer WB, David MM, Nadeau KC, Kraft M, Bime C, Schaenman J, Erle D, Calfee CS, Atkinson MA, Brackenridge SC, Ehrlich LIR, Montgomery RR, Shaw AC, Hough CL, Geng LN, Hafler DA, Augustine AD, Becker PM, Peters B, Ozonoff A, Kim-Schulze SH, Krammer F, Bosinger S, Eckalbar W, Altman MC, Wilson M, Guan L, Kleinstein SH, Smolen KK, Reed EF, Levy O, Maecker H, Hunt P, Steen H, Diray-Arce J, Langelier CR, Melamed E
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19. bioRxiv. 2024 Nov 16.
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19.
Baden LR, Swaminathan S, Almyroudis NG, Angarone M, Baluch A, Barros N, Buss B, Cohen S, Cooper B, Chiang AD, Boghdadly ZE, Gregg K, Hakim H, Ho D, Khawaja F, Lee R, Lee F, Logan C, Manley K, Multani A, Pande A, Pergam S, Pisano J, Saullo J, Schuster M, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Zimmer A, Cassara CJ, Kumar R, Diwan Z
Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 Nov; 22(9):617-644.
Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.
Pickering H, Schaenman J, Phan HV, Maguire C, Tsitsiklis A, Rouphael N, Higuita NIA, Atkinson MA, Brakenridge S, Fung M, Messer W, Salehi-Rad R, Altman MC, Becker PM, Bosinger SE, Eckalbar W, Hoch A, Doni Jayavelu N, Kim-Schulze S, Jenkins M, Kleinstein SH, Krammer F, Maecker HT, Ozonoff A, Diray-Arce J, Shaw A, Baden L, Levy O, Reed EF, Langelier CR
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients. Nat Commun. 2025 Jan 10; 16(1):586.
Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients.
Follmann D, Wang X, Baden LR, El Sahly HM, Essink B, Gilbert P, Janes HE, Kelley CF, Berman MA, Frank I, Chu E, Deng W, Priddy F, Dixit A, Tomassini JE, Das R, Miller J, Zhou H
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial. Open Forum Infect Dis. 2024 Dec; 11(12):ofae689.
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial.
Zhang B, Fong Y, Dang L, Fintzi J, Chen S, Wang J, Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Graciaa DS, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Yu C, Magaret CA, Molitor C, Borate B, Busch S, Benkeser D, Netzl A, Smith DJ, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Mu J, Makowski M, Makhene MK, Nayak SU, Roberts PC, Gilbert PB, Follmann D
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost. Nat Commun. 2025 Jan 17; 16(1):759.
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.
Kakoullis L, Alonso CD, Burns R, Aleissa MM, Haddad EA, Kim AJ, Rooks R, Yates B, Kanwal U, Morreale NP, Morgan A, Arnaout R, Tong A, Izaguirre NE, Little JS, Hammond SP, Montgomery MW, Sherman AC, Maguire JH, Woolley AE, Baden LR, Issa NC, Harris CE
Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study. Clin Infect Dis. 2025 Dec 24; 81(5):987-994.
Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study.
Mauskopf J, Chirila C, Graham J, Gersten ID, Leather H, Maziarz RT, Baden LR, Bolaños-Meade J, Brown JM, Walsh TJ, Horowitz MH, Kurtzberg J, Marr KA, Wingard JR
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants. Am J Health Syst Pharm. 2013 Sep 01; 70(17):1518-27.
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
Gabernet G, Maciuch J, Gygi JP, Moore JF, Hoch A, Syphurs C, Chu T, Jayavelu ND, Corry DB, Kheradmand F, Baden LR, Sekaly RP, McComsey GA, Haddad EK, Cairns CB, Rouphael N, Fernandez-Sesma A, Simon V, Metcalf JP, Agudelo Higuita NI, Hough CL, Messer WB, Davis MM, Nadeau KC, Pulendran B, Kraft M, Bime C, Reed EF, Schaenman J, Erle DJ, Calfee CS, Atkinson MA, Brackenridge SC, Melamed E, Shaw AC, Hafler DA, Ozonoff A, Bosinger SE, Eckalbar W, Maecker HT, Kim-Schulze S, Steen H, Krammer F, Westendorf K, Peters B, Fourati S, Altman MC, Levy O, Smolen KK, Montgomery RR, Diray-Arce J, Kleinstein SH, Guan L, Ehrlich LIR
Identification of a multi-omics factor predictive of long COVID in the IMPACC study. bioRxiv. 2025 Feb 14.
Identification of a multi-omics factor predictive of long COVID in the IMPACC study.
Jayavelu ND, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA, Sekaly RP, Cairns CB, Haddad EK, Schaenman J, Shaw AC, Hafler DA, Montgomery RR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Geng LN, Sesma AF, Simon V, Krammer F, Kraft M, Bime C, Calfee CS, Erle DJ, Langelier CR, Guan L, Maecker HT, Peters B, Kleinstein SH, Reed EF, Diray-Arce J, Rouphael N, Altman MC
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors. medRxiv. 2025 Feb 13.
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.
Angelidou A, Koster JA, Sherman AC, McLoughlin C, Lalwani P, Kelly A, Saeed A, McEnaney K, Baden LR, Brogna M, Weitzman ER, Levy S, Dowling DJ, Levy O
Product and trial design considerations on the path towards a vaccine to combat opioid overdose. NPJ Vaccines. 2025 Feb 19; 10(1):35.
Product and trial design considerations on the path towards a vaccine to combat opioid overdose.
Dryden-Peterson S, Kim A, Caniglia EC, Joyce MR, Rubins D, Kim AY, Fangman J, Baden LR, Woolley AE
Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study. PLoS One. 2025; 20(2):e0316529.
Severe outcomes of COVID-19 among adults with increased risk conditions: A population-based observational study.
A Comprehensive Approach to Understanding Vaccine-Induced Seropositivity (VISP) in HIV Vaccine Clinical Trial Participants
Rubin EJ, Baden LR, Weaver LM, Morrissey S
NEJM Outbreaks Update - H5N1 in Indiana. N Engl J Med. 2025 May 15; 392(19):e47.
NEJM Outbreaks Update - H5N1 in Indiana.
Rubin EJ, Baden LR, Goldstein R, Shuford JA, Morrissey S
NEJM Outbreaks Update - H5N1: A View from the States. N Engl J Med. 2025 Apr 03; 392(13):e37.
NEJM Outbreaks Update - H5N1: A View from the States.
Moodie Z, Li SS, Giorgi EE, Williams LD, Dintwe O, Carpp LN, Chen S, Seaton KE, Sawant SS, Zhang L, Heptinstall J, Liu S, Grunenberg N, Tomaka F, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Ake JA, Vasan S, Pantaleo G, Frank I, Baden LR, Goepfert PA, Keefer M, Chirenje M, Hosseinipour MC, Mngadi K, Laher F, Garrett N, Bekker LG, De Rosa S, Andersen-Nissen E, Kublin JG, Lu S, Gilbert PB, Gray GE, Corey L, McElrath MJ, Tomaras GD
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials. Emerg Microbes Infect. 2025 Dec; 14(1):2485317.
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials.
Haynes BF, Saunders KO, Hahn BH, Wiehe K, Baden LR, Shaw GM
Journal of the International AIDS Society
Status of HIV vaccine development: progress and promise. J Int AIDS Soc. 2025 May; 28(5):e26489.
Status of HIV vaccine development: progress and promise.
Rubin EJ, Baden LR, Kawaoka Y, Morrissey S
NEJM Outbreaks Update - H5N1. N Engl J Med. 2025 Mar 27; 392(12):e34.
Fisher LH, Lazarus E, Yu C, Moodie Z, Stieh DJ, Yates N, Zhang L, Sawant S, De Rosa SC, Cohen KW, Morris D, Grant S, Randhawa A, Miner MD, Hendriks J, Wegmann F, Gill KM, Laher F, Bekker LG, Gray GE, Corey L, McElrath MJ, Martin T, Gilbert PB, Tomaras G, Walsh SR, Baden LR
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost. PLOS Glob Public Health. 2025; 5(4):e0004250.
ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost.
Riddler SA, Moodie Z, Clark J, Yen C, Allen M, Furch BD, Lu H, Grant S, Mondal K, Anderson M, Maenza J, Lemos MP, Woodward Davis AS, Walsh SR, Sobieszczyk ME, Frank I, Goepfert P, Stephenson KE, Baden LR, Tieu HV, Keefer MC, McElrath MJ, Kublin JG, Corey L
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Ann Intern Med. 2025 Jul; 178(7):963-974.
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).
Issa NC, Marty FM, Leblebjian H, Galar A, Shea MM, Antin JH, Soiffer RJ, Baden LR
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2014 Feb; 20(2):285-7.
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.
Nadig N, Bhimraj A, Cawcutt K, Chiotos K, Dzierba AL, Kim AY, Martin GS, Pearson JC, Shumaker AH, Baden LR, Bedimo R, Cheng VC, Chew KW, Daar ES, Glidden DV, Hardy EJ, Johnson S, Li JZ, MacBrayne C, Nakamura MM, Riley L, Shafer RW, Shoham S, Tebas P, Tien PC, Loveless J, Falck-Ytter Y, Morgan RL, Gandhi RT
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i13-i16.
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.
Qualls AE, Tsao T, Lui I, Lim SA, Su Y, Chen E, Duchen D, Maecker HT, Kim-Schulze S, Montgomery RR, Krammer F, Langelier CR, Levy O, Baden LR, Melamed E, Ehrlich LI, McComsey GA, Sekaly RP, Cairns CB, Haddad EK, Shaw AC, Hafler DA, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Higuita NIA, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Fernandez-Sesma A, Simon V, Kraft M, Bime C, Calfee CS, Erle DJ, Schaenmann J, Ozonoff A, Peters B, Kleinstein SH, Augustine AD, Diray-Arce J, Becker PM, Rouphael N, Goldman JD, Calabrese DR, Heath JR, Wells JA, Reed EF, Lanier LL, Pickering H, Aguilar OA
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19. JCI Insight. 2025 Jul 08; 10(13).
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19.
For an influenza vaccine, are two Bs better than one? N Engl J Med. 2013 Dec 26; 369(26):2547-9.
For an influenza vaccine, are two Bs better than one?
Rorije NM, Shea MM, Satyanarayana G, Hammond SP, Ho VT, Baden LR, Antin JH, Soiffer RJ, Marty FM
BK virus disease after allogeneic stem cell transplantation: a cohort analysis. Biol Blood Marrow Transplant. 2014 Apr; 20(4):564-70.
BK virus disease after allogeneic stem cell transplantation: a cohort analysis.
Nguyen AN, Kouyate TS, Ryff K, Plotkin AL, Doss-Gollin S, Thomas S, McEnaney K, Ozonoff A, Diray-Arce J, Levy O, Odumade OA, Baden LR, van Haren SD, Smolen KK
Patients Hospitalized with COVID-19 Demonstrate Distinct Plasma Cytokine and Chemokine Concentrations in vivo and TLR-Mediated Cytokine and Chemokine Production in Whole Blood in vitro. J Innate Immun. 2025; 17(1):288-301.
Patients Hospitalized with COVID-19 Demonstrate Distinct Plasma Cytokine and Chemokine Concentrations in vivo and TLR-Mediated Cytokine and Chemokine Production in Whole Blood in vitro.
Cheng MP, Gonzalez-Bocco IH, Arbonna-Haddad E, Aleissa M, Chen K, Zhou E, Beluch K, Cho A, Burchett S, Moulton E, Desjardins M, Baden LR, Koo S, Letourneau AR, Hammond SP, Ritz J, Soiffer R, Issa NC, Kim HT, Sherman AC
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study. J Assoc Med Microbiol Infect Dis Can. 2025 Mar; 10(1):6-14.
Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection or Disease or with Concurrent Organ Dysfunction: A Phase 2 Open Label Study.
Mzava O, Agun GF, Loy CJ, Gonzalez-Bocco IH, Djomnang Kounatse LA, Bliss A, Wells SL, Lenz J, Belcher E, Chen K, Koo S, Baden LR, Chu T, Cheng MP, Ritz J, Gupta S, De Vlaminck I
Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications. Clin Chem. 2025 Oct 03; 71(10):1058-1066.
Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications.
Phase 1 study of a SARS-CoV-2 vaccine adjuvanted via controlled biodistribution of mRNA encoding spike protein and IL-12p70
Sherman AC, Gray GE, Cao B, To KKW, Rouphael N, Henao-Restrepo AM, Gordon AC, Baden LR
Acute SARS-CoV-2 infection. Nat Rev Dis Primers. 2025 Oct 24; 11(1):75.
Pneumonia in the immunocompromised host. Curr Opin Pulm Med. 2014 May; 20(3):272-9.
Pneumonia in the immunocompromised host.
Galar A, Engelson BA, Kubiak DW, Licona JH, Boukedes S, Goldberg HJ, Baden LR, Marty FM, Issa NC
Serologic response to hepatitis B vaccination among lung transplantation candidates. Transplantation. 2014 Sep 27; 98(6):676-9.
Serologic response to hepatitis B vaccination among lung transplantation candidates.
Doni Jayavelu N, Samaha H, Wimalasena ST, Hoch A, Gygi JP, Gabernet G, Ozonoff A, Liu S, Milliren CE, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA, Sekaly RP, Cairns CB, Haddad EK, Schaenman J, Shaw AC, Hafler DA, Montgomery RR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Agudelo Higuit NI, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Geng LN, Fernandez Sesma A, Simon V, Krammer F, Kraft M, Bime C, Calfee CS, Erle DJ, Langelier CR, Guan L, Maecker HT, Peters B, Kleinstein SH, Reed EF, Augustine AD, Diray-Arce J, Becker PM, Rouphael N, Altman MC
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors. Commun Med (Lond). 2026 Jan 03; 6(1):1.
Wheat LJ, Nguyen MH, Alexander BD, Denning D, Caliendo AM, Lyon GM, Baden LR, Marty FM, Clancy C, Kirsch E, Noth P, Witt J, Sugrue M, Wingard JR
Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens. J Clin Microbiol. 2014 Jun; 52(6):2108-11.
Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.
Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. J Clin Microbiol. 2014 Jun; 52(6):2199-201.
Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, Buchbinder SP, Hammer SM, Koblin BA, Pensiero M, Butler C, Moss B, Robinson HL
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J Infect Dis. 2014 Jul 01; 210(1):99-110.
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
Baden LR, Walsh SR, Seaman MS, Johnson JA, Tucker RP, Kleinjan JA, Gothing JA, Engelson BA, Carey BR, Oza A, Bajimaya S, Peter L, Bleckwehl C, Abbink P, Pau MG, Weijtens M, Kunchai M, Swann EM, Wolff M, Dolin R, Barouch DH
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002). J Infect Dis. 2014 Oct 01; 210(7):1052-61.
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).
Follmann D, Dang L, Chu E, Fintzi J, Janes H, Gilbert PB, Andrews LIB, Serebryannyy L, Carroll R, Lin B, Koup R, Toma J, Deng W, Priddy F, Dixit A, Zhou H, Baden L, El Sahly HM
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples. J Infect Dis. 2026 Mar 17; 233(3):e646-e650.
A Test-Negative Design for Immune Correlates Approximates a Traditional Exposure-Proximal Design but Requires Far Fewer Blood Samples.
Frey SE, Baden LR, El Sahly HM, Davey RT, Rebolledo PA, Diemert DJ, Little SJ, Creech CB, Oikonomopoulou Z, Sherman AC, Whitaker JA, Rouphael NG, Desrosiers A, Martin TCS, Rolsma SL, Hoet B, Watanabe A, Jaunarajs A, Moss B, Tomashek KM, Lerner A, Beigel JH
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination. Vaccine. 2026 Jan 01; 69:127959.
Evaluation of the safety and immunogenicity of two fractional intradermal regimens of MVA-BN compared to standard dose vaccination.
Hill JA, Pergam SA, Halasa NB, Kumar D, Baden LR, Boeckh MJ
A Network for Advancing Prevention and Treatment of Infections Among Immunocompromised Individuals. JAMA Netw Open. 2025 Aug 01; 8(8):e2528383.
A Network for Advancing Prevention and Treatment of Infections Among Immunocompromised Individuals.
Xu J, Halloran ME, Moore M, Zhang L, Hyrien O, Luedtke A, El Sahly HM, Baden LR, Goepfert PA, Gray G, Grinsztejn B, Sobieszczyk ME, Falsey AR, Robinson ST, Garcia NMG, Zhou H, van Dromme I, Truyers C, Hirsch I, Neuzil KM, Corey L, Kublin JG, Follmann D, Janes HE, Gilbert PB, Huang Y
Association between COVID-19 vaccine efficacy and epidemic force of infection. NPJ Vaccines. 2026 Jan 17; 11(1):54.
Association between COVID-19 vaccine efficacy and epidemic force of infection.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans. Cell. 2025 Nov 13; 188(23):6688-6689.
Coppolino A, Maurer R, Woehl E, Connolly EM, Chamberlin E, Goldberg HJ, Jacob SS, Lee SF, Kennedy JC, Sheikh A, O'Neill AJ, Gupta S, Hernandez Acosta RA, Kovac V, Keshk M, Hackmann A, Dunning J, Sharma NS, Baden LR, Woolley AE
Bronchial stenosis after lung transplant: Risk factors and clinical outcomes. JHLT Open. 2026 Feb; 11:100392.
Bronchial stenosis after lung transplant: Risk factors and clinical outcomes.
Hammond SP, Buckley MW, Petruzziello G, Koo S, Marty FM, Baden LR
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Clinical characteristics and outcomes of clostridial bacteraemia in cancer patients. Clin Microbiol Infect. 2014 Aug; 20(8):752-757.
Clinical characteristics and outcomes of clostridial bacteraemia in cancer patients.
Goepfert P, Katz MJ, Kaul D, Sharma T, Kaur D, Falck-Ytter Y, Baden L
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patients. Clin Infect Dis. 2026 Feb 28.
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal Influenza infections in immunocompromised patients.
Nellore A, Bajema K, Belden K, Blumberg D, York E, Falck-Ytter Y, Baden LR
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients. Clin Infect Dis. 2026 Feb 25.
IDSA 2025 Guidelines on the use of vaccines for the prevention of seasonal COVID-19 infections in immunocompromised patients.
Managing Individual and Community Risk - Broad-Spectrum Antimicrobial Use. NEJM Evid. 2025 Jul; 4(7):EVIDe2500070.
Managing Individual and Community Risk - Broad-Spectrum Antimicrobial Use.
Bhimraj A, Falck-Ytter Y, Baden LR, Bedimo R, Cawcutt K, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Johnson S, Kim AY, Li JZ, MacBrayne C, Martin GS, Nadig N, Nakamura MM, Pearson JC, Riley L, Shafer RW, Shoham S, Shumaker AH, Tebas P, Tien PC, Loveless J, Morgan RL, Gandhi RT
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness. Clin Infect Dis. 2026 Jan 16; 81(Supplement_3):i1-i5.
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness.
Ashby E, Janes H, Follmann D, Gilbert PB, Zhou H, Wang X, Girard B, Priddy F, Kublin JG, Corey L, Neuzil KM, Baden LR, El Sahly HM, Zhang B
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up. Am J Epidemiol. 2026 Jan 08; 195(1):168-177.
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-up.
Little JS, Hebert KM, Neuberg DS, Nikiforow S, Gooptu M, Shapiro RM, Koreth J, Antin JH, Cutler C, Soiffer RJ, Ritz J, Romee R, Ho VT, Issa NC, Baden LR, Duléry R, Prockop SE
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell Transplantation. Transplant Cell Ther. 2026 Jan; 32(1):98.e1-98.e11.
Expression of HLA-B*35 is Associated With an Increased Risk of CMV Viremia and Clinically Significant CMV Infection following PTCy-Based Hematopoietic Cell Transplantation.
Sacks CA, Wappes J, Rasmussen SA, Goodman RA, Walensky RP, Goldstein RH, Rubin E, Baden LR, Corey Hardin C, Osterholm MT
Public Health Alerts - A New Section in NEJM Evidence, in Partnership with CIDRAP. NEJM Evid. 2026 Feb; 5(2):EVIDe2500346.
Public Health Alerts - A New Section in NEJM Evidence, in Partnership with CIDRAP.
Marwah HK, Pearl A, Burke AE, Koscal N, Ling E, Baden LR
Measles. N Engl J Med. 2025 Dec 18; 393(24):e40.
Khanwalkar US, Fields J, Wiener JA, Lindman ML, Balazs AB, Seaman MS, Baden LR, Walsh SR, Fiering SN, Huang YH, Ackerman ME
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge. bioRxiv. 2025 Nov 13.
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.
Malkin E, Zaric M, Kieh M, Baden LR, Fitz-Patrick D, Marini A, Yun H, Hayes P, Bromell R, Ayorinde M, Fernandez N, Varma R, Sigei F, Ward M, Pindolia H, Sewell S, Amini F, Blie J, Wilson B, Faley P, McCullough J, Tokpah F, Wisseh C, Towalid E, Hadawale S, Sayeed E, Hunt D, Keshavarzi N, Barin B, Maljkovic Berry I, Parks CL, Truter SG, Walker K, Vekemans J, Lehrman J, Engelbrecht M, Malherbe M, Laufer D, Philiponis V, Higgs E, Mutua G, Fast PE, Gupta SB
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate. N Engl J Med. 2025 Nov 06; 393(18):1807-1818.
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate.
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors. Commun Med (Lond). 2026 Feb 23; 6(1).
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factors.
Hudson A, Borgetti S, Rick AM, Laurens MB, Robinson ST, Gay CL, Baden LR, Goepfert PA, Rouphael N, El Sahly HM, Gray GE, Grinsztejn B, Sobieszczyk ME, Falsey AR, Huang Y, Janes H, Follmann D, Koup RA, Priddy F, Hendriks J, Shoemaker K, Dunkle LM, de Bruyn G, Devlin L, Neuzil KM, Kublin JG, Corey L, Walsh SR, Kotloff KL, Gilbert PB
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials. Vaccine. 2026 Apr 02; 77:128380.
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.
Krause KH, Lewis-O'Connor A, Berger A, Votto T, Yawetz S, Pallin DJ, Baden LR
Women's health issues : official publication of the Jacobs Institute of Women's Health
Current practice of HIV postexposure prophylaxis treatment for sexual assault patients in an emergency department. Womens Health Issues. 2014 Jul-Aug; 24(4):e407-12.
Current practice of HIV postexposure prophylaxis treatment for sexual assault patients in an emergency department.
Innis CJ, Braverman H, Cavin JM, Ceresia ML, Baden LR, Kuhn DM, Frasca S, McGowan JP, Hirokawa K, Weber ES, Stacy B, Merigo C
Journal of the American Veterinary Medical Association
Diagnosis and management of Enterococcus spp infections during rehabilitation of cold-stunned Kemp's ridley turtles (Lepidochelys kempii): 50 cases (2006-2012). J Am Vet Med Assoc. 2014 Aug 01; 245(3):315-23.
Diagnosis and management of Enterococcus spp infections during rehabilitation of cold-stunned Kemp's ridley turtles (Lepidochelys kempii): 50 cases (2006-2012).
Dagogo-Jack I, Vaidya A, Geller B, Baden LR, Stone R
Interactive medical case. A man with fever, cough, and rash. N Engl J Med. 2014 Aug 21; 371(8):e11.
Interactive medical case. A man with fever, cough, and rash.
Baden LR, Kanapathipillai R, Campion EW, Morrissey S, Rubin EJ, Drazen JM
Ebola--an ongoing crisis. N Engl J Med. 2014 Oct 09; 371(15):1458-9.
Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan". J Clin Microbiol. 2014 Nov; 52(11):4119.
Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan".
Koo S, Thomas HR, Daniels SD, Lynch RC, Fortier SM, Shea MM, Rearden P, Comolli JC, Baden LR, Marty FM
A breath fungal secondary metabolite signature to diagnose invasive aspergillosis. Clin Infect Dis. 2014 Dec 15; 59(12):1733-40.
A breath fungal secondary metabolite signature to diagnose invasive aspergillosis.
Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, Levy Y, Gilbert P, deCamp A, Russell ND, Elizaga M, Allen M, Corey L
Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants. Clin Vaccine Immunol. 2014 Nov; 21(11):1589-99.
Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.
Bayingana R, Mutua G, Mpendo J, Kilembe W, Omosa-Manyonyi G, Ruzagirwa E, Page-Shipp L, Gray G, Bekker LG, Baden L, Hayes P, Dally L, Schmidt C, Laufer D, Priddy F, Fast P, Gilmour J, Cox J
Overweight BMI and Alcohol Use Are Associated with Immune Responses in Phase I HIV Vaccine Trials. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A186-7.
Overweight BMI and Alcohol Use Are Associated with Immune Responses in Phase I HIV Vaccine Trials.
Liao LH, Trama AM, Williams WB, Moody MA, Vandergrift N, Tomaras GD, Marshall DJ, Gurley T, Whitesides J, Eudailey J, Foulger A, Parks R, Stolarchuk C, Lloyd KE, Soderberg K, Mascola JR, Koup R, Corey L, Nabel GB, Gilber P, Morgan C, Maenza J, Keefer M, Hammer S, Churchyard G, Montefior DC, Graham BS, Baden LR, Kepler TB, Haynes BF
Role of Intestinal Microbiota in Shaping the B Cell Repertoire in HIV Infection and Env Vaccination. AIDS Res Hum Retroviruses. 2014 Oct; 30 Suppl 1:A19.
Role of Intestinal Microbiota in Shaping the B Cell Repertoire in HIV Infection and Env Vaccination.
Baden LR, Liu J, Li H, Johnson JA, Walsh SR, Kleinjan JA, Engelson BA, Peter L, Abbink P, Milner DA, Golden KL, Viani KL, Stachler MD, Chen BJ, Pau MG, Weijtens M, Carey BR, Miller CA, Swann EM, Wolff M, Loblein H, Seaman MS, Dolin R, Barouch DH
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans. J Infect Dis. 2015 Feb 15; 211(4):518-28.
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
Drazen JM, Kanapathipillai R, Campion EW, Rubin EJ, Hammer SM, Morrissey S, Baden LR
Ebola and quarantine. N Engl J Med. 2014 Nov 20; 371(21):2029-30.
Out of Africa--caring for patients with Ebola. N Engl J Med. 2014 Dec 18; 371(25):2430-2.
Out of Africa--caring for patients with Ebola.
Hammond SP, Swaminathan S, Bensinger WI, Baden LR
Hepatitis B virus screening and potential reactivation in patients undergoing treatment for cancer. J Natl Compr Canc Netw. 2014 Dec; 12(12):1655-7.
Hepatitis B virus screening and potential reactivation in patients undergoing treatment for cancer.
Rabin AS, Givertz MM, Couper GS, Shea MM, Peixoto D, Yokoe DS, Baden LR, Marty FM, Koo S
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Risk factors for invasive fungal disease in heart transplant recipients. J Heart Lung Transplant. 2015 Feb; 34(2):227-32.
Risk factors for invasive fungal disease in heart transplant recipients.
Peixoto D, Hammond SP, Issa NC, Madan R, Gill RR, Milner DA, Colson YL, Koo S, Baden LR, Marty FM
Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease. Open Forum Infect Dis. 2014 Mar; 1(1):ofu014.
Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease.
Drazen JM, Campion EW, Rubin EJ, Morrissey S, Baden LR
Ebola in West Africa at one year--from ignorance to fear to roadblocks. N Engl J Med. 2015 Feb 05; 372(6):563-4.
Ebola in West Africa at one year--from ignorance to fear to roadblocks.
Williams WB, Liao HX, Moody MA, Kepler TB, Alam SM, Gao F, Wiehe K, Trama AM, Jones K, Zhang R, Song H, Marshall DJ, Whitesides JF, Sawatzki K, Hua A, Liu P, Tay MZ, Seaton KE, Shen X, Foulger A, Lloyd KE, Parks R, Pollara J, Ferrari G, Yu JS, Vandergrift N, Montefiori DC, Sobieszczyk ME, Hammer S, Karuna S, Gilbert P, Grove D, Grunenberg N, McElrath MJ, Mascola JR, Koup RA, Corey L, Nabel GJ, Morgan C, Churchyard G, Maenza J, Keefer M, Graham BS, Baden LR, Tomaras GD, Haynes BF
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science. 2015 Aug 14; 349(6249):aab1253.
HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.
Loechelt BJ, Green M, Gottlieb PA, Blumberg E, Weinberg A, Quinlan S, Baden LR
Journal of the Pediatric Infectious Diseases Society
Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders. J Pediatric Infect Dis Soc. 2015 Sep; 4(3):198-204.
Screening and Monitoring for Infectious Complications When Immunosuppressive Agents Are Studied in the Treatment of Autoimmune Disorders.
Waks AG, Tolaney SM, Galar A, Arnaout A, Porter JB, Marty FM, Winer EP, Hammond SP, Baden LR
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors. Breast Cancer Res Treat. 2015 Nov; 154(2):359-67.
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.
Walsh SR, Moodie Z, Fiore-Gartland AJ, Morgan C, Wilck MB, Hammer SM, Buchbinder SP, Kalams SA, Goepfert PA, Mulligan MJ, Keefer MC, Baden LR, Swann EM, Grant S, Ahmed H, Li F, Hertz T, Self SG, Friedrich D, Frahm N, Liao HX, Montefiori DC, Tomaras GD, McElrath MJ, Hural J, Graham BS, Jin X
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083. J Infect Dis. 2016 Feb 15; 213(4):541-50.
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
Chung AW, Kumar MP, Arnold KB, Yu WH, Schoen MK, Dunphy LJ, Suscovich TJ, Frahm N, Linde C, Mahan AE, Hoffner M, Streeck H, Ackerman ME, McElrath MJ, Schuitemaker H, Pau MG, Baden LR, Kim JH, Michael NL, Barouch DH, Lauffenburger DA, Alter G
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology. Cell. 2015 Nov 05; 163(4):988-98.
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.
Brasier AR, Zhao Y, Spratt HM, Wiktorowicz JE, Ju H, Wheat LJ, Baden L, Stafford S, Wu Z, Issa N, Caliendo AM, Denning DW, Soman K, Clancy CJ, Nguyen MH, Sugrue MW, Alexander BD, Wingard JR
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens. PLoS One. 2015; 10(11):e0143165.
Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
Kubiak DW, Farmakiotis D, Arons V, Hollins RM, Rostas SE, Weiser LM, Baden LR, Marty FM, Koo S
Diagnostic microbiology and infectious disease
Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia. Diagn Microbiol Infect Dis. 2016 Mar; 84(3):223-6.
Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.
Global Health Access Program (GHAP) at Mae Tao Clinic, Mae Sot, Thailand
Farmakiotis D, Liakos A, Miller MB, Krane JF, Baden LR, Hammond SP
An Avid Imitator. J Clin Med Res. 2016 Mar; 8(3):257-9.
Baden LR, Karita E, Mutua G, Bekker LG, Gray G, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S, Laher F, Innes C, Seaman MS, Cohen YZ, Peter L, Frahm N, McElrath MJ, Hayes P, Swann E, Grunenberg N, Grazia-Pau M, Weijtens M, Sadoff J, Dally L, Lombardo A, Gilmour J, Cox J, Dolin R, Fast P, Barouch DH, Laufer DS
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial. Ann Intern Med. 2016 Mar 01; 164(5):313-22.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Zika Virus and Microcephaly. N Engl J Med. 2016 Mar 10; 374(10):984-5.
Mahan AE, Jennewein MF, Suscovich T, Dionne K, Tedesco J, Chung AW, Streeck H, Pau M, Schuitemaker H, Francis D, Fast P, Laufer D, Walker BD, Baden L, Barouch DH, Alter G
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016 Mar; 12(3):e1005456.
Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination.
Identification of leishmania species responsible for Cutaneous Leishmaniasis in Mali.
Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 07; 14(7):882-913.
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.
Hope WW, Walsh TJ, Goodwin J, Peloquin CA, Howard A, Kurtzberg J, Mendizabal A, Confer DL, Bulitta J, Baden LR, Neely MN, Wingard JR
The Journal of antimicrobial chemotherapy
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial. J Antimicrob Chemother. 2016 08; 71(8):2234-40.
Voriconazole pharmacokinetics following HSCT: results from the BMT CTN 0101 trial.
van Haren SD, Dowling DJ, Foppen W, Christensen D, Andersen P, Reed SG, Hershberg RM, Baden LR, Levy O
Journal of immunology (Baltimore, Md. : 1950)
Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016 12 01; 197(11):4413-4424.
Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.
Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, Sobieszczyk ME, Mayer KH, Swann E, Liao HX, Haynes BF, Graham BS, McElrath MJ
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals. J AIDS Clin Res. 2015 May; 6(5).
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.
Schlimgen R, Howard J, Wooley D, Thompson M, Baden LR, Yang OO, Christiani DC, Mostoslavsky G, Diamond DV, Duane EG, Byers K, Winters T, Gelfand JA, Fujimoto G, Hudson TW, Vyas JM
Journal of occupational and environmental medicine
Risks Associated With Lentiviral Vector Exposures and Prevention Strategies. J Occup Environ Med. 2016 12; 58(12):1159-1166.
Risks Associated With Lentiviral Vector Exposures and Prevention Strategies.
Infectious disease clinics of North America
Gastrointestinal infections in the immunocompromised host. Infect Dis Clin North Am. 2001 Jun; 15(2):639-70, xi.
Gastrointestinal infections in the immunocompromised host.
Baden LR, Katz JT, Franck L, Tsang S, Hall M, Rubin RH, Jarcho J
Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation. 2003 Feb 15; 75(3):339-43.
Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole.
Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006 Jul 01; 43(1):16-24.
Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.
Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, Baden LR
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood. 2003 Oct 15; 102(8):2768-76.
Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.
Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathog. 2016 Jun; 12(6):e1005694.
Correction: Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination.
Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis. 2008 Sep 01; 47(5):674-83.
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Zaia J, Baden L, Boeckh MJ, Chakrabarti S, Einsele H, Ljungman P, McDonald GB, Hirsch H
Viral disease prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009 Oct; 44(8):471-82.
Viral disease prevention after hematopoietic cell transplantation.
Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia. Curr Hematol Malig Rep. 2007 May; 2(2):97-103.
Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia.
Specialty and training differences in the reported use of endocarditis prophylaxis at an academic medical center. Am J Med. 2001 Dec 01; 111(8):657-60.
Specialty and training differences in the reported use of endocarditis prophylaxis at an academic medical center.
Baden LR, Katz JT, Fishman JA, Koziol C, DelVecchio A, Doran M, Rubin RH
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Transplantation. 2003 Dec 15; 76(11):1632-7.
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy.
The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients. Transplantation. 2004 Feb 15; 77(3):356-7.
The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients.
Lin MT, Levy ML, Bowden PE, Magro C, Baden L, Baden HP, Roop DR
Identification of sporadic mutations in the helix initiation motif of keratin 6 in two pachyonychia congenita patients: further evidence for a mutational hot spot. Exp Dermatol. 1999 Apr; 8(2):115-9.
Identification of sporadic mutations in the helix initiation motif of keratin 6 in two pachyonychia congenita patients: further evidence for a mutational hot spot.
Prestes DP, Arbona E, Nevett-Fernandez A, Woolley AE, Ho VT, Koo S, Baden LR, Koreth J, Hammond SP, Issa NC, Marty FM
Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation. Clin Infect Dis. 2017 Aug 01; 65(3):510-513.
Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation.
Impact of Antibiotic Resistance on the Treatment of Gram-negative Sepsis. Curr Infect Dis Rep. 2000 Oct; 2(5):409-416.
Impact of Antibiotic Resistance on the Treatment of Gram-negative Sepsis.
Goepfert PA, Horton H, McElrath MJ, Gurunathan S, Ferrari G, Tomaras GD, Montefiori DC, Allen M, Chiu YL, Spearman P, Fuchs JD, Koblin BA, Blattner WA, Frey S, Keefer MC, Baden LR, Corey L
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects. J Infect Dis. 2005 Oct 01; 192(7):1249-59.
High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects.
Alsan MM, Issa NC, Hammond SP, Milner DA, DeAngelo DJ, Baden LR
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2011 Aug; 11(4):375-7.
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia.
Koo S, Kubiak DW, Issa NC, Dietzek A, Boukedes S, Camp PC, Goldberg HJ, Baden LR, Fuhlbrigge AL, Marty FM
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis. Transplantation. 2012 Aug 15; 94(3):281-6.
A targeted peritransplant antifungal strategy for the prevention of invasive fungal disease after lung transplantation: a sequential cohort analysis.
Ellerin T, Hurtado R, Lockman S, Baden L
Fever in a returned traveler: an "off the cuff" diagnosis. Clin Infect Dis. 2003 Apr 15; 36(8):1004-5, 1074-5.
Fever in a returned traveler: an "off the cuff" diagnosis.
Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy. J Natl Compr Canc Netw. 2008 Feb; 6(2):202-13.
Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy.
Baden LR, Critchley IA, Sahm DF, So W, Gedde M, Porter S, Moellering RC, Eliopoulos G
Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin. J Clin Microbiol. 2002 Apr; 40(4):1160-3.
Molecular characterization of vancomycin-resistant Enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin.
Fever, neutropenia, and the second law of thermodynamics. Ann Intern Med. 2002 Jul 16; 137(2):123-4.
Fever, neutropenia, and the second law of thermodynamics.
Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011 Mar; 17(3):434-8.
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Baden LR, Curfman GD, Morrissey S, Drazen JM
Human papillomavirus vaccine--opportunity and challenge. N Engl J Med. 2007 May 10; 356(19):1990-1.
Human papillomavirus vaccine--opportunity and challenge.
Posaconazole for invasive aspergillosis? Clin Infect Dis. 2007 Sep 01; 45(5):664; author reply 665-6.
Posaconazole for invasive aspergillosis?
Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004 Sep 30; 351(14):1391-402.
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
Baden LR, Horowitz G, Jacoby H, Eliopoulos GM
Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA. 2001 Dec 26; 286(24):3115-9.
Quinolones and false-positive urine screening for opiates by immunoassay technology.
Clinical decisions. Management of incidental hepatitis C virus infection--polling results. N Engl J Med. 2009 Jun 04; 360(23):e30.
Clinical decisions. Management of incidental hepatitis C virus infection--polling results.
Goepfert PA, Elizaga ML, Sato A, Qin L, Cardinali M, Hay CM, Hural J, DeRosa SC, DeFawe OD, Tomaras GD, Montefiori DC, Xu Y, Lai L, Kalams SA, Baden LR, Frey SE, Blattner WA, Wyatt LS, Moss B, Robinson HL
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles. J Infect Dis. 2011 Mar 01; 203(5):610-9.
Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
LaRocque RC, Katz JT, Perruzzi P, Baden LR
The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus. Clin Infect Dis. 2003 Nov 15; 37(10):1380-3.
The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus.
Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK
Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol. 2006 Feb; 44(2):595-7.
Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Winston DJ, Baden LR, Gabriel DA, Emmanouilides C, Shaw LM, Lange WR, Ratanatharathorn V
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract. Biol Blood Marrow Transplant. 2006 Jun; 12(6):635-40.
Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of the gastrointestinal tract.
Infectious complications associated with immunomodulating biologic agents. Infect Dis Clin North Am. 2010 Jun; 24(2):285-306.
Infectious complications associated with immunomodulating biologic agents.
Baden LR, Bensinger W, Angarone M, Casper C, Dubberke ER, Freifeld AG, Garzon R, Greene JN, Greer JP, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marr KA, Montoya JG, Morris-Engemann A, Pappas PG, Rolston K, Segal B, Seo SK, Swaminathan S, Naganuma M, Shead DA
Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw. 2012 Nov 01; 10(11):1412-45.
Graham JV, Baden L, Tsiodras S, Karchmer AW
Q fever endocarditis associated with extensive serological cross-reactivity. Clin Infect Dis. 2000 Mar; 30(3):609-10.
Q fever endocarditis associated with extensive serological cross-reactivity.
Wingard JR, Carter SL, Walsh TJ, Kurtzberg J, Small TN, Baden LR, Gersten ID, Mendizabal AM, Leather HL, Confer DL, Maziarz RT, Stadtmauer EA, Bolaños-Meade J, Brown J, Dipersio JF, Boeckh M, Marr KA
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood. 2010 Dec 09; 116(24):5111-8.
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
Baden LR, Blattner WA, Morgan C, Huang Y, Defawe OD, Sobieszczyk ME, Kochar N, Tomaras GD, McElrath MJ, Russell N, Brandariz K, Cardinali M, Graham BS, Barouch DH, Dolin R
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects. J Infect Dis. 2011 Nov 15; 204(10):1541-9.
Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects.
Hammond SP, Gagne LS, Stock SR, Marty FM, Gelman RS, Marasco WA, Poritz MA, Baden LR
Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods. J Clin Microbiol. 2012 Oct; 50(10):3216-21.
Respiratory virus detection in immunocompromised patients with FilmArray respiratory panel compared to conventional methods.
Hammond SP, Marty FM, Bryar JM, DeAngelo DJ, Baden LR
Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Am J Hematol. 2010 Sep; 85(9):695-9.
Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
Hematology/oncology clinics of North America
Infectious complications associated with immunomodulating biologic agents. Hematol Oncol Clin North Am. 2011 Feb; 25(1):117-38.
Guzmán-Suarez BB, Buckley MW, Gilmore ET, Vocca E, Moss R, Marty FM, Sanders R, Baden LR, Wurtman D, Issa NC, Fang F, Koo S
Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients. Transpl Infect Dis. 2012 Aug; 14(4):427-33.
Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients.
The road to an effective HIV vaccine. N Engl J Med. 2012 Apr 05; 366(14):1343-4.
Current issues in vaccines for adult patients with hematologic malignancies. J Natl Compr Canc Netw. 2012 Nov 01; 10(11):1447-54; quiz 1454.
Current issues in vaccines for adult patients with hematologic malignancies.
Buchbinder SP, Grunenberg NA, Sanchez BJ, Seaton KE, Ferrari G, Moody MA, Frahm N, Montefiori DC, Hay CM, Goepfert PA, Baden LR, Robinson HL, Yu X, Gilbert PB, McElrath MJ, Huang Y, Tomaras GD
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults. PLoS One. 2017; 12(7):e0179597.
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.
Koo S, Bryar JM, Page JH, Baden LR, Marty FM
Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis. 2009 Dec 01; 49(11):1650-9.
Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
Barouch DH, Kik SV, Weverling GJ, Dilan R, King SL, Maxfield LF, Clark S, Ng'ang'a D, Brandariz KL, Abbink P, Sinangil F, de Bruyn G, Gray GE, Roux S, Bekker LG, Dilraj A, Kibuuka H, Robb ML, Michael NL, Anzala O, Amornkul PN, Gilmour J, Hural J, Buchbinder SP, Seaman MS, Dolin R, Baden LR, Carville A, Mansfield KG, Pau MG, Goudsmit J
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine. 2011 Jul 18; 29(32):5203-9.
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.
Increasing access to thoracic organs from donors infected with hepatitis C: A previous challenge-now an opportunity. J Heart Lung Transplant. 2018 05; 37(5):681-683.
Increasing access to thoracic organs from donors infected with hepatitis C: A previous challenge-now an opportunity.
Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001 Aug 15; 33(4):562-9.
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.
Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2006 May; 12(5):552-9.
Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
Duke-Cohan JS, Wollenick K, Witten EA, Seaman MS, Baden LR, Dolin R, Reinherz EL
The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays. Vaccine. 2009 Feb 18; 27(8):1154-65.
The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.
Koblin BA, Casapia M, Morgan C, Qin L, Wang ZM, Defawe OD, Baden L, Goepfert P, Tomaras GD, Montefiori DC, McElrath MJ, Saavedra L, Lau CY, Graham BS
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. PLoS One. 2011; 6(9):e24517.
Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial.
Issa NC, Koo S, Lynch RC, Gay C, Hammond SP, Baden LR, Ghobrial IM, Finkelman MA, Marty FM
Serum galactomannan and (1->3)-ß-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia. J Clin Microbiol. 2012 Mar; 50(3):1054-6.
Serum galactomannan and (1->3)-ß-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.
Solomon DH, Van Houten L, Glynn RJ, Baden L, Curtis K, Schrager H, Avorn J
Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med. 2001 Aug 13-27; 161(15):1897-902.
Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center.
Fungal infections of the CNS: treatment strategies for the immunocompromised patient. CNS Drugs. 2007; 21(4):293-318.
Fungal infections of the CNS: treatment strategies for the immunocompromised patient.
Baden LR, Rubin EJ, Morrissey S, Farrar JJ, Drazen JM
We Can Do Better - Improving Outcomes in the Midst of an Emergency. N Engl J Med. 2017 10 12; 377(15):1482-1484.
We Can Do Better - Improving Outcomes in the Midst of an Emergency.
Human herpesvirus 6 encephalitis. Curr Infect Dis Rep. 2008 Jul; 10(4):292-9.
Post-diagnostic kinetics of the (1 ? 3)-ß-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia. Clin Microbiol Infect. 2012 May; 18(5):E122-7.
Post-diagnostic kinetics of the (1 ? 3)-ß-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.
Knoll BM, Kappagoda S, Gill RR, Goldberg HJ, Boyle K, Baden LR, Fuhlbrigge AL, Marty FM
Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis. 2012 Oct; 14(5):452-60.
Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
Schwarzberg AB, Stover EH, Sengupta T, Michelini A, Vincitore M, Baden LR, Kulke MH
Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. Cancer Invest. 2007 Jun; 25(4):249-55.
Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial. PLoS Med. 2017 Nov; 14(11):e1002435.
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
Case records of the Massachusetts General Hospital. Weekly Clinicopathological exercises. Case 4-2003. A 42-year-old woman with cough, fever, and abnormalities on thoracoabdominal computed tomography. N Engl J Med. 2003 Jan 30; 348(5):447-55.
Case records of the Massachusetts General Hospital. Weekly Clinicopathological exercises. Case 4-2003. A 42-year-old woman with cough, fever, and abnormalities on thoracoabdominal computed tomography.
Seaman MS, Wilck MB, Baden LR, Walsh SR, Grandpre LE, Devoy C, Giri A, Noble LC, Kleinjan JA, Stevenson KE, Kim HT, Dolin R
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J Infect Dis. 2010 May 01; 201(9):1353-60.
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.
Walsh SR, Wilck MB, Dominguez DJ, Zablowsky E, Bajimaya S, Gagne LS, Verrill KA, Kleinjan JA, Patel A, Zhang Y, Hill H, Acharyya A, Fisher DC, Antin JH, Seaman MS, Dolin R, Baden LR
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial. J Infect Dis. 2013 Jun 15; 207(12):1888-97.
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.
Philips JA, Marty FM, Stone RM, Koplan BA, Katz JT, Baden LR
Torsades de pointes associated with voriconazole use. Transpl Infect Dis. 2007 Mar; 9(1):33-6.
Torsades de pointes associated with voriconazole use.
Gorse GJ, Baden LR, Wecker M, Newman MJ, Ferrari G, Weinhold KJ, Livingston BD, Villafana TL, Li H, Noonan E, Russell ND
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults. Vaccine. 2008 Jan 10; 26(2):215-23.
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults.
Baden LR, Drazen JM, Kritek PA, Curfman GD, Morrissey S, Campion EW
H1N1 influenza A disease--information for health professionals. N Engl J Med. 2009 Jun 18; 360(25):2666-7.
H1N1 influenza A disease--information for health professionals.
Herrera AF, Soriano G, Bellizzi AM, Hornick JL, Ho VT, Ballen KK, Baden LR, Cutler CS, Antin JH, Soiffer RJ, Marty FM
Cord colitis syndrome in cord-blood stem-cell transplantation. N Engl J Med. 2011 Sep 01; 365(9):815-24.
Cord colitis syndrome in cord-blood stem-cell transplantation.
Mulholland K, Suara RO, Siber G, Roberton D, Jaffar S, N'Jie J, Baden L, Thompson C, Anwaruddin R, Dinan L, Glezen WP, Francis N, Fritzell B, Greenwood BM
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. JAMA. 1996 Apr 17; 275(15):1182-8.
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia.
Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM
Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009 Sep; 15(9):1049-59.
Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR, Marty FM
Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011 Jun; 49(6):2151-3.
Molecular methods to improve diagnosis and identification of mucormycosis.
Smoking status and the electrocardiogram: a cross-sectional and longitudinal study. Arch Environ Health. 1982 Nov-Dec; 37(6):365-9.
Smoking status and the electrocardiogram: a cross-sectional and longitudinal study.